<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.1d2 20140930//EN" "JATS-archivearticle1.dtd"> 
<article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="research-article"><?DTDIdentifier.IdentifierValue -//ES//DTD journal article DTD version 5.2.0//EN//XML?><?DTDIdentifier.IdentifierType public?><?SourceDTD.DTDName art520.dtd?><?SourceDTD.Version 5.2.0?><?ConverterInfo.XSLTName elsevier2nlmx2.xsl?><?ConverterInfo.Version 2?><?origin publisher?><?FILEmeta_MOLMET206 xml ?><?FILEmain xml ?><?FILEmain pdf ?><?FILEgr1 jpg ?><?FILEgr2 jpg ?><?FILEgr3 jpg ?><?FILEgr4 jpg ?><?FILEgr5 jpg ?><?FILEgr6 jpg ?><?FILEgr7 jpg ?><?properties open_access?><front><journal-meta><journal-id journal-id-type="nlm-ta">Mol Metab</journal-id><journal-id journal-id-type="iso-abbrev">Mol Metab</journal-id><journal-title-group><journal-title>Molecular Metabolism</journal-title></journal-title-group><issn pub-type="epub">2212-8778</issn><publisher><publisher-name>Elsevier</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="pmcid">4354924</article-id><article-id pub-id-type="publisher-id">S2212-8778(15)00004-6</article-id><article-id pub-id-type="doi">10.1016/j.molmet.2015.01.003</article-id><article-categories><subj-group subj-group-type="heading"><subject>Original Article</subject></subj-group></article-categories><title-group><article-title>Clic4, a novel protein that sensitizes <bold>&#x003b2;</bold>-cells to apoptosis<sup><xref ref-type="fn" rid="d32e571">a</xref></sup></article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Patel</surname><given-names>Dhaval</given-names></name><xref rid="aff1" ref-type="aff">1</xref></contrib><contrib contrib-type="author"><name><surname>Ythier</surname><given-names>Damien</given-names></name><xref rid="aff1" ref-type="aff">1</xref></contrib><contrib contrib-type="author"><name><surname>Brozzi</surname><given-names>Flora</given-names></name><xref rid="aff2" ref-type="aff">2</xref></contrib><contrib contrib-type="author"><name><surname>Eizirik</surname><given-names>Decio L.</given-names></name><xref rid="aff2" ref-type="aff">2</xref></contrib><contrib contrib-type="author"><name><surname>Thorens</surname><given-names>Bernard</given-names></name><email>bernard.thorens@unil.ch</email><xref rid="aff1" ref-type="aff">1</xref><xref rid="cor1" ref-type="corresp">&#x02217;</xref></contrib></contrib-group><aff id="aff1"><label>1</label>Center for Integrative Genomics, University of Lausanne, Genopode Building, CH-1015 Lausanne, Switzerland</aff><aff id="aff2"><label>2</label>ULB Center for Diabetes Research, Universit&#x000e9; Libre de Bruxelles (ULB), Brussels, Belgium</aff><author-notes><corresp id="cor1"><label>&#x02217;</label>Corresponding author. Tel.:&#x000a0;+41 21 692 3981; fax:&#x000a0;+41 21 692 3985. <email>bernard.thorens@unil.ch</email></corresp></author-notes><pub-date pub-type="pmc-release"><day>20</day><month>1</month><year>2015</year></pub-date><!-- PMC Release delay is 0 months and 0 days and was based on <pub-date						pub-type="epub">.--><pub-date pub-type="collection"><month>4</month><year>2015</year></pub-date><pub-date pub-type="epub"><day>20</day><month>1</month><year>2015</year></pub-date><volume>4</volume><issue>4</issue><fpage>253</fpage><lpage>264</lpage><history><date date-type="received"><day>17</day><month>12</month><year>2014</year></date><date date-type="rev-recd"><day>6</day><month>1</month><year>2015</year></date><date date-type="accepted"><day>9</day><month>1</month><year>2015</year></date></history><permissions><copyright-statement>&#x000a9; 2015 The Authors</copyright-statement><copyright-year>2015</copyright-year><license license-type="CC BY-NC-ND" xlink:href="http://creativecommons.org/licenses/by-nc-nd/4.0/"><license-p>This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).</license-p></license></permissions><abstract><sec><title>Objectives</title><p>Chloride intracellular channel protein 4 (Clic4) is a ubiquitously expressed protein involved in multiple cellular processes including cell-cycle control, cell differentiation, and apoptosis. Here, we investigated the role of Clic4 in pancreatic &#x003b2;-cell apoptosis.</p></sec><sec><title>Methods</title><p>We used &#x003b2;TC-tet cells and islets from &#x003b2;-cell specific Clic4 knockout mice (&#x003b2;Clic4KO) and assessed cytokine-induced apoptosis, Bcl2 family protein expression and stability, and identified Clic4-interacting proteins by co-immunoprecipitation and mass spectrometry analysis.</p></sec><sec><title>Results</title><p>We show that cytokines increased Clic4 expression in &#x003b2;TC-tet cells and in mouse islets and siRNA-mediated silencing of Clic4 expression in &#x003b2;TC-tet cells or its genetic inactivation in islets &#x003b2;-cells, reduced cytokine-induced apoptosis. This was associated with increased expression of Bcl-2 and increased expression and phosphorylation of Bad. Measurement of Bcl-2 and Bad half-lives in &#x003b2;TC-tet cells showed that Clic4 silencing increased the stability of these proteins. In primary islets &#x003b2;-cells, absence of Clic4 expression increased Bcl-2 and Bcl-xL expression as well as expression and phosphorylation of Bad. Mass-spectrometry analysis of proteins co-immunoprecipitated with Clic4 from &#x003b2;TC-tet cells showed no association of Clic4 with Bcl-2 family proteins. However, Clic4 co-purified with proteins from the proteasome suggesting a possible role for Clic4 in regulating protein degradation.</p></sec><sec><title>Conclusions</title><p>Collectively, our data show that Clic4 is a cytokine-induced gene that sensitizes &#x003b2;-cells to apoptosis by reducing the steady state levels of Bcl-2, Bad and phosphorylated Bad.</p></sec></abstract><kwd-group><title>Keywords</title><kwd>Clic4</kwd><kwd>&#x003b2;-cells</kwd><kwd>Apoptosis</kwd><kwd>Cytokines</kwd><kwd>Bcl-2</kwd><kwd>Diabetes</kwd></kwd-group></article-meta></front><body><sec sec-type="intro" id="sec1"><label>1</label><title>Introduction</title><p>A complete destruction of pancreatic &#x003b2;-cells, caused by an autoimmune reaction, underlies the development of type 1 diabetes <xref rid="bib1" ref-type="bibr">[1]</xref>. In type 2 diabetes, a partial reduction in &#x003b2;-cell mass is also observed and may contribute to the impaired capacity of the endocrine pancreas to secrete enough insulin to compensate for the development of insulin resistance in peripheral tissues <xref rid="bib2" ref-type="bibr">[2]</xref>. The destruction of &#x003b2;-cells in Type 1 diabetes is mediated by pro-inflammatory cytokines, such as IL-1&#x003b2;, IFN-&#x003b3; and TNF-&#x003b1; <xref rid="bib1 bib3" ref-type="bibr">[1,3]</xref>, and by other pro-apoptotic mediators provided by activated immune cells, such as FasL and perforins/granzymes <xref rid="bib4 bib5" ref-type="bibr">[4,5]</xref>. In type 2 diabetes, pancreatic islets also show signs of inflammation with infiltrating macrophages <xref rid="bib6" ref-type="bibr">[6]</xref> and increased production of cytokines and chemokines by the islet cells themselves <xref rid="bib7 bib8" ref-type="bibr">[7,8]</xref>. Evidence for toxic effects of elevated glucose and saturated free fatty acid levels (glucolipotoxicity) on &#x003b2;-cells is well established <xref rid="bib9 bib10 bib11 bib12 bib13" ref-type="bibr">[9&#x02013;13]</xref>, and energy-dense diets, rich in refined sugars and saturated fats can contribute to loss of functional &#x003b2;-cells through apoptosis. Cytokines (IL-1&#x003b2;, IFN-&#x003b3; and TNF-&#x003b1;) induce apoptosis following binding to their specific receptors and activation of NF-&#x003ba;B, STAT1 and JNK <xref rid="bib14 bib15 bib16" ref-type="bibr">[14&#x02013;16]</xref>, leading to activation of pro-apoptotic Bcl-2 family proteins <xref rid="bib17" ref-type="bibr">[17]</xref>. These proteins interact with anti-apoptotic Bcl-2 proteins through their Bcl-2 homology 3 (BH3) domain in a hierarchical way <xref rid="bib18" ref-type="bibr">[18]</xref>. The balance and interaction between these proteins decides cell fate by activating or inactivating pro-death proteins Bax and Bak <xref rid="bib19 bib20" ref-type="bibr">[19,20]</xref>, which then triggers apoptosis following mitochondrial outer membrane permeabilization (MOMP) <xref rid="bib21" ref-type="bibr">[21]</xref>. Saturated free fatty acids are thought to induce apoptosis in large part through an initial activation of the ER stress pathway <xref rid="bib10" ref-type="bibr">[10]</xref> that leads to activation of protein kinase R-like ER kinase (PERK), inositol requiring 1 (IRE1) and activating transcription factor 6 (ATF6). However, this ultimately also converges on the activation of the pro-apoptotic Bcl2 family proteins that activate mitochondrial outer membrane permeabilization and caspase 3-dependent apoptosis <xref rid="bib22 bib23" ref-type="bibr">[22,23]</xref>.</p><p>Because both forms of diabetes are associated with apoptosis-dependent loss of &#x003b2;-cell mass, identifying novel proteins involved in the control of apoptosis may lead to novel approaches to preserve &#x003b2;-cell mass and the insulin secretion capacity of the endocrine pancreas.</p><p>Clic4 (chloride intracellular channel 4) is a 28&#x000a0;kDa protein, which was initially cloned from rat brain <xref rid="bib24" ref-type="bibr">[24]</xref> and proposed to be a chloride channel because of its homology to p64, a member of the chloride ion channel family <xref rid="bib24 bib25" ref-type="bibr">[24,25]</xref>; this proposed channel function, however, has not been supported by more recent studies <xref rid="bib26" ref-type="bibr">[26]</xref>. In contrast, Clic4 has been implicated in regulating cell cycle arrest, cell differentiation, and apoptosis, <xref rid="bib27 bib28 bib29 bib30 bib31" ref-type="bibr">[27&#x02013;31]</xref>. In keratinocytes, Clic4 is up-regulated by TNF-&#x003b1; <xref rid="bib32" ref-type="bibr">[32]</xref> and in p53- or c-myc-mediated apoptosis <xref rid="bib33 bib34" ref-type="bibr">[33,34]</xref>. Clic4 is found in the cytosol but under some conditions it may be associated with mitochondria or the nucleus and increase apoptosis through cytochrome c release from mitochondria and caspase-3 activation <xref rid="bib32 bib35" ref-type="bibr">[32,35]</xref>.</p><p>Here, we investigated the role of Clic4 in pancreatic &#x003b2;-cell apoptosis by suppressing <italic>Clic4</italic> expression in &#x003b2;TC-tet cells or by using islets from &#x003b2;-cell specific conditional Clic4 knockout mice (<italic>&#x003b2;Clic4KO</italic>). We showed that siRNA-mediated Clic4 silencing in &#x003b2;TC-tet cells or its genetic inactivation in islets &#x003b2;-cells reduces the sensitivity of these cells to cytokines- or palmitic acid-induced apoptosis. Moreover, we show that <italic>Clic4</italic> knockdown reduces the degradation rate of Bcl-2 and Bad and increases the total level of phosphorylated Bad, possibly as a result of Clic4 interaction with the proteasome.</p></sec><sec sec-type="materials|methods" id="sec2"><label>2</label><title>Materials and methods</title><sec id="sec2.1"><label>2.1</label><title>Reagents</title><p>TNF-&#x003b1; and IL-1&#x003b2; were purchased from Calbiochem (Nyon, Switzerland); IFN-&#x003b3;, palmitic acid, cycloheximide from Sigma (St. Louis, MO); exendin-4 from Bachem AG (Bubendorf, Switzerland); protease and phosphatase inhibitors were from Roche (Rotkreuz, Switzerland); other reagents were of analytical or cell culture grade purity.</p></sec><sec id="sec2.2"><label>2.2</label><title>Antibodies</title><p>Rabbit anti-actin and mouse anti-&#x003b1;-tubulin were from Sigma (St. Louis, MO); rabbit antibodies to caspase-3, Bcl2, Bcl-xL, Bad, phospho-Bad (ser-112) and Bax were from Cell signaling (Danvers, MA, USA); rabbit antibodies to phospho-Bim (ser-69), Bim, Puma, phospho-SAPK/JNK (Thr-183/Tyr-185), SAPK/JNK were from Cell signaling. Secondary horseradish peroxidase (HRP) conjugated anti-rabbit IgG (from donkey) and HRP conjugated anti-mouse IgG (from sheep) were from GE healthcare (Nyon, Switzerland).</p></sec><sec id="sec2.3"><label>2.3</label><title>Cell culture</title><p>The mouse pancreatic &#x003b2;TC-tet cell line <xref rid="bib36" ref-type="bibr">[36]</xref> were grown in Dulbecco's modified Eagle's medium&#x000a0;+&#x000a0;glutamax (Gibco, Zug, Switzerland), supplemented with 15% horse serum, 2.5% fetal bovine serum, 10&#x000a0;mM HEPES, 1&#x000a0;mM sodium pyruvate at 37&#x000a0;&#x000b0;C in a CO2 incubator and used between passages 20 and 35.</p><p>Min6(B1) cells <xref rid="bib37" ref-type="bibr">[37]</xref> were grown in Dulbecco's modified Eagle's medium&#x000a0;+&#x000a0;glutamax, supplemented with 15% heat-inactivated fetal calf serum, 71&#x000a0;&#x003bc;M &#x003b2;-mercaptoethanol and used between passages 19 and 30.</p></sec><sec id="sec2.4"><label>2.4</label><title>Clic4 specific siRNA and reverse transfection</title><p>The <italic>Clic4</italic> specific siRNA (<italic>siClic4</italic>) has the following sequence: CCG CAA CTT TGA TAT TCC TAA AGG A (Invitrogen, Zug, Switzerland). Cells were reverse transfected by diluting 150&#x000a0;nM of <italic>siClic4</italic> or <italic>siCT</italic> (negative control siRNA, Invitrogen, Zug, Switzerland) in serum free medium in a tissue culture plate; 7.5&#x000a0;&#x003bc;l of Lipofectamine RNAiMax (Invitrogen, Zug, Switzerland) was then added and incubated at room temperature for 20&#x000a0;min to form Lipid-siRNA complex. The complex was diluted to five times with growth medium containing 1&#x000a0;&#x000d7;&#x000a0;10<sup>6</sup> &#x003b2;TC-tet cells to obtain a final siRNA concentration of 30&#x000a0;nM. The transfected cells were incubated at 37&#x000a0;&#x000b0;C in a CO2 incubator (medium was replaced after every 24&#x000a0;h) and were used for the experiments, 48&#x000a0;h&#x000a0;after transfection.</p></sec><sec id="sec2.5"><label>2.5</label><title>Generation of <bold>&#x003b2;</bold>-cell specific Clic4 conditional knockout mice</title><p>Clic4 floxed mice were generated by homologous recombination in embryonic stem cells using the strategy depicted in <xref rid="fig5" ref-type="fig">Figure&#x000a0;5</xref>A (Genoway, Lyon, France). The neo cassette was removed by crossing Clic4<sup>lox/+</sup> mice with Flp-deleter mice. The neomycin negative male Clic4<sup>lox/+</sup> mice were then crossed with female Ins1<sup>Cre/+</sup> mice <xref rid="bib38" ref-type="bibr">[38]</xref> to generate Clic4<sup>lox/+</sup>; Ins1<sup>Cre/+</sup> and Clic4<sup>lox/+</sup> mice. Mice with homozygous &#x003b2;-cell deletion of Clic4 were generated by crossing Clic4<sup>lox/+</sup>; Ins1<sup>Cre/+</sup> mice with Clic4<sup>lox/+</sup> mice in order to obtain Clic4<sup>lox/lox</sup>; Ins1 <sup>Cre/+</sup> mice (<italic>&#x003b2;Clic4KO</italic>) and control littermates (Control). Mice were on a C57BL/6 background. All studies were performed with littermates. Mice were housed on a 12-h&#x000a0;light/dark cycle and fed a standard rodent chow (Diet 3436; Provimi Kliba AG, Penthallaz, Switzerland).</p></sec><sec id="sec2.6"><label>2.6</label><title>Islets isolation and culture</title><p>Islets were isolated from 8 to 12-week-old mice as described in Ref. <xref rid="bib39" ref-type="bibr">[39]</xref> and, after handpicking, they were kept overnight in RPMI-1640 medium (Gibco, Zug, Switzerland), supplemented with 10% FBS, 2&#x000a0;mM Glutamax, 100&#x000a0;units/ml penicillin, and 100&#x000a0;&#x003bc;g/ml streptomycin. Islets were then kept in suspension for western blot analysis or for apoptosis and proliferation experiments. For other experiments (see Section <xref rid="sec2.7" ref-type="sec">2.7</xref>), 20 islets were plated on tissue culture dishes coated with an extracellular matrix (ECM) derived from bovine corneal endothelial cells (Novamed, Jerusalem, Israel) for 6&#x02013;7 days to form monolayers, before starting treatment.</p></sec><sec id="sec2.7"><label>2.7</label><title>Cell treatment</title><p>For apoptosis measurements, &#x003b2;TC-tet cells or pancreatic islets were treated with cytokines (25&#x000a0;ng/ml TNF-&#x003b1;, 10&#x000a0;ng/ml IL-1&#x003b2; and 10&#x000a0;ng/ml IFN-&#x003b3;) for 15&#x000a0;h, or treated with 100&#x000a0;nM exendin-4 for 24&#x000a0;h or 48&#x000a0;h, or treated for 48&#x000a0;h&#x000a0;with 1&#x000a0;mM palmitic acid (a stock solution containing 10&#x000a0;mM palmitic acid and 20% fatty acid-free bovine serum albumin (BSA) was prepared by dissolving 34.8&#x000a0;mg sodium palmitate in 4&#x000a0;ml of phosphate buffered saline (PBS) at &#x0223c;70&#x000a0;&#x000b0;C, and adding 2.5&#x000a0;g of fatty acid-free BSA dissolved in 8&#x000a0;ml of PBS, the final volume was brought to 12.5&#x000a0;ml with PBS and stored in aliquots at&#x000a0;&#x02212;20&#x000a0;&#x000b0;C).</p></sec><sec id="sec2.8"><label>2.8</label><title>Clic4 antibody generation</title><p>Clic4 C-terminal and N-terminal peptides (MALSMPLNGLKEEDKEPC and CKEVEIAYSDVAKRLTK, respectively) were conjugated to keyhole limpet hemocyanin and used to immunize New Zealand White rabbits. Immunization consisted in one boost injection and repeated challenges with 1&#x000a0;mg of peptides. The rabbits were killed after a total of five injections for serum collection and specific antibodies were purified by affinity chromatography. Antibody production was made by Biotem (Grenoble, France).</p></sec><sec id="sec2.9"><label>2.9</label><title>Gel electrophoresis and western blot</title><p>&#x003b2;TC-tet cells or mouse islets were washed twice with cold PBS and lysed on ice for 20&#x000a0;min&#x000a0;in a buffer containing 50&#x000a0;mM Tris, pH 7.5, 0.1% SDS, 1% Nonidet P40, 150&#x000a0;mM NaCl, 5&#x000a0;mM EDTA, 0.5% sodium deoxycholate, and protease and phosphatase inhibitors. Lysates were sonicated for 15&#x000a0;s, centrifuged at 12,000&#x000a0;g for 10&#x000a0;min&#x000a0;at 4&#x000a0;&#x000b0;C and supernatants were collected. The protein concentrations were determined by BCA assay (Thermo scientific, Erembodegem, Belgium) and equal amounts of protein lysates were resolved by 12% SDS-PAGE and transferred onto a nitrocellulose membrane. The membranes were incubated with the appropriate primary antibodies and revealed using horseradish peroxidase-conjugated secondary antibodies and enhanced chemiluminescence detection reagents (Advansta, CA, USA); quantification of the band density was performed by densitometric analysis.</p></sec><sec id="sec2.10"><label>2.10</label><title>Apoptosis assay</title><p>Apoptotic cells were identified by TUNEL assay using In Situ Cell Death Detection Kit, Fluorescein (Roche, Rotkreuz, Switzerland). Cell nuclei were stained with 4&#x02032;,6-diamidino-2-phenylindole (DAPI). The signals were visualized with a fluorescence microscope Leica (Nidau, Switzerland). Photomicrographs were captured under green (TUNEL positive) and blue (DAPI positive) channels at 20&#x000d7; magnification and merged using the Leica software. Each condition reported represents &#x0003e;2500 cells (&#x003b2;TC-tet cells or islet cells) counted by randomized field selection. The apoptosis is reported as the percent of TUNEL positive nuclei over the total number of nuclei stained by DAPI, as quantitated by Image J software (<ext-link ext-link-type="uri" xlink:href="http://rsbweb.nih.gov/ij/" id="intref0010">http://rsbweb.nih.gov/ij/</ext-link>).</p></sec><sec id="sec2.11"><label>2.11</label><title>Quantitative real-time PCR</title><p>Total RNA was extracted from islets and &#x003b2;TC-tet cells using RNeasy Plus micro kit (Qiagen, Hombrechtikon, Switzerland) and RNeasy mini kit (Qiagen, Hombrechtikon, Switzerland), respectively, and cDNAs were synthesized using SuperScript<sup>&#x000ae;</sup> II Reverse Transcriptase (Invitrogen, Zug, Switzerland) according to the manufacturer's instructions. Expression of target genes was measured by real time quantitative PCR (qRT-PCR) using 7500 Fast Real-Time PCR System (Applied Biosystems; Zug, Switzerland) in a final volume of 10&#x000a0;&#x003bc;l containing 2&#x000a0;&#x003bc;l of cDNA and 5&#x000a0;&#x003bc;l of power SYBR Green PCR mix (Applied Biosystems; Zug, Switzerland), in the presence of forward and reverse primers. Expression values were normalized to the expression of the housekeeping gene TATA-box binding protein (TBP). Primer sequences are: for Bcl-2 (F) 5&#x02032;-GATGACTGAGTACCTGAACCG-3&#x02032;, (R) 5&#x02032;-CAGAGACAGCCAGGAGAAATC-3&#x02032;; for Bcl-xL (F) 5&#x02032;-GGAAAGCGTAGACAAGGAGATG-3&#x02032;, (R) 5&#x02032;-GCATTGTTCCCGTAGAGATCC-3&#x02032;; for Bad (F) 5&#x02032;-AGGATGAGCGATGAGTTTGAG-3&#x02032;, (R) 5&#x02032;-CCTTTGCCCAAGTTTCGATC-3&#x02032;; for Clic4 (F) 5&#x02032;-GACAAAGAGCCCCTCATCGA-3&#x02032;, (R) 5&#x02032;-GTTTCCAATGCTTTCACCATC-3&#x02032;; TBP (F) 5&#x02032;-ATCCCAAGCGATTTGCTGC-3&#x02032;, (R) 5&#x02032;-ACTCTTGGCTCCTGTGCACA-3&#x02032;. All the primers were obtained from Microsynth (Balgach, Switzerland).</p></sec><sec id="sec2.12"><label>2.12</label><title>Immunoprecipitation and LC&#x02013;MS/MS analysis</title><p>&#x003b2;TC-tet cells were lysed in the immunoprecipitation buffer (20&#x000a0;mM Tris, pH-7.4, 100&#x000a0;mM NaCl, 0.5% NP40 containing protease and phosphatase inhibitors). One mg of cell lysate proteins was incubated overnight with 7&#x000a0;&#x003bc;g of anti-Clic4 C-terminus, anti-Clic4 N-terminus, or rabbit IgGs at 4&#x000a0;&#x000b0;C with gentle rocking. After centrifugation at 13,000&#x000a0;rpm for 10&#x000a0;min&#x000a0;at 4&#x000a0;&#x000b0;C the supernatants were collected and added on Protein G-Agarose beads (Roche, Rotkreuz, Switzerland), incubated for 2&#x000a0;h at 4&#x000a0;&#x000b0;C with gentle rocking and washed four times with the immunoprecipitation buffer. After washing, beads were heated in sample buffer (75&#x000a0;mM Tris, pH-6.8, 5% &#x003b2;-mercaptoethanol, 10% glycerol, 2.5% SDS) for 5&#x000a0;min at 95&#x000a0;&#x000b0;C and used for western blotting or mass-spectrometric (MS) analysis.</p><p>For mass-spectrometric analysis, immunoprecipitates were fractionated by electrophoresis on a polyacrylamide gel and stained with Coomassie blue. Gel lanes were cut into six equal regions from top to bottom. They were then reduced by dithiothreitol, alkylated with iodoacetamide and digested with trypsin (Promega, Madison, USA) as described in Ref. <xref rid="bib40 bib41" ref-type="bibr">[40,41]</xref>. Liquid chromatography&#x02013;MS/MS analysis of the extracted peptide mixtures was carried out on a hybrid linear trap LTQ-Orbitrap XL (Thermo Scientific, Waltham, USA) mass spectrometer interfaced to a nanocapillary HPLC equipped with a C18 reversed-phase column (Thermo Scientific). Collection of tandem mass spectra for database searching were generated from raw data with Mascot Distiller and searched using Mascot 2.4.1 (Matrix Science, London, UK) against the release 2012_11 of the SwissProt database (<ext-link ext-link-type="uri" xlink:href="http://www.uniprot.org" id="intref0015">www.uniprot.org</ext-link>) restricted to Mus musculus taxonomy. Mascot was searched with a fragment ion mass tolerance of 0.50&#x000a0;Da and a parent ion tolerance of 10&#x000a0;ppm, allowing two missed cleavages. Iodoacetamide derivative of cysteine was specified as a fixed modification. Protein N-term acetylation, deamidation of asparagine and glutamine, and oxidation of methionine were specified as variable modifications. The software Scaffold (version Scaffold_4.1.1, Proteome Software Inc.) was used to validate MS/MS based peptide (minimum 90% probability <xref rid="bib42" ref-type="bibr">[42]</xref>, with delta-mass correction) and protein (min. 95% probability <xref rid="bib43" ref-type="bibr">[43]</xref>) identifications. Dataset&#x000a0;alignment as well as parsimony analysis to discriminate homologous hits was carried out by Scaffold. Proteins sharing significant peptide evidence were grouped into clusters.</p></sec><sec id="sec2.13"><label>2.13</label><title>Glucose stimulated insulin secretion (GSIS)</title><p>&#x003b2;TC-tet cells or Min6(B1) were transfected with <italic>siCT</italic> or <italic>siClic4</italic>. 72&#x000a0;h&#x000a0;later, they were washed with PBS and pre-incubated for 2&#x000a0;h in KRBH-BSA (Krebs-Ringer bicarbonate HEPES buffer containing 120&#x000a0;mM NaCl, 4&#x000a0;mM KH2PO4, 20&#x000a0;mM HEPES, 1&#x000a0;mM MgCl2, 1&#x000a0;mM CaCl2, 5&#x000a0;mM NaHCO3, and 0.5% BSA, pH7.4) supplemented with 2&#x000a0;mM glucose, later the medium was replaced with fresh KRBH-BSA containing 2 or 20&#x000a0;mM glucose and incubated for 1&#x000a0;h in the presence or absence of 100&#x000a0;nM Exendin-4. Secreted and cellular insulin were assessed by radioimmunoassay (RIA) using RIA kit (Millipore, MA, USA) following manufacturer's instructions.</p></sec><sec id="sec2.14"><label>2.14</label><title>Study approval</title><p>All breeding and cohort maintenance were performed in the UNIL animal facility, and all the experiments were approved by the Service V&#x000e9;t&#x000e9;rinaire du Canton de Vaud, Switzerland.</p></sec><sec id="sec2.15"><label>2.15</label><title>Statistical analysis</title><p>The results are expressed as the means&#x000a0;&#x000b1;&#x000a0;S.D. Comparisons were performed using unpaired Student's <italic>t</italic> test or one-way analysis of variance for the different groups followed by posthoc pairwise multiple-comparison procedures with the Tukey test. Single, double, and triple asterisks indicate statistically significant differences (*<italic>p</italic>&#x000a0;&#x0003c;&#x000a0;0.05; **<italic>p</italic>&#x000a0;&#x0003c;&#x000a0;0.01; ***<italic>p</italic>&#x000a0;&#x0003c;&#x000a0;0.001).</p></sec></sec><sec sec-type="results" id="sec3"><label>3</label><title>Results</title><sec id="sec3.1"><label>3.1</label><title>Clic4 expression is induced by cytokines and its silencing protects against apoptosis</title><p>We first investigated whether Clic4 protein expression in &#x003b2;TC-tet cells and primary mouse islets was increased by cytokines treatment. <xref rid="fig1" ref-type="fig">Figure&#x000a0;1</xref>A,B, shows that a 15&#x000a0;h&#x000a0;treatment with Il-1&#x003b2;, TNF&#x003b1; and IFN&#x003b3; increased Clic4 protein expression by &#x0223c;30% in &#x003b2;TC-tet cells and by &#x0223c;100% in primary mouse islets (<xref rid="fig1" ref-type="fig">Figure&#x000a0;1</xref>C,D).</p><p>To assess the effect of <italic>Clic4</italic> silencing on cytokines-induced apoptosis, we transfected &#x003b2;TC-tet cells with a control or a <italic>Clic4</italic>-specific siRNA and assessed cytokine-induced apoptosis, in the presence or absence of 100&#x000a0;nM exendin-4 added 9&#x000a0;h&#x000a0;prior to the addition of cytokines. <xref rid="fig1" ref-type="fig">Figure&#x000a0;1</xref>F shows an &#x0223c;3-fold increase in apoptosis upon cytokine treatment in <italic>siCT</italic>-transfected cells and a complete protection against apoptosis by exendin-4. Upon <italic>Clic4</italic> silencing, the basal rate of apoptosis was reduced by 50% as compared to <italic>siCT</italic>-transfected cells and cytokines increased apoptosis by 2-fold, to a level that was still &#x0223c;3-fold lower than in <italic>siCT</italic>-transfected cells; exendin-4 still significantly reduced cytokine-induced apoptosis. The extent of siRNA-mediated <italic>Clic4</italic> silencing is shown by western blot analysis in <xref rid="fig1" ref-type="fig">Figure&#x000a0;1</xref>E.</p><p>We also assessed apoptosis by measuring caspase-3 cleavage by western blot analysis. <xref rid="fig1" ref-type="fig">Figure&#x000a0;1</xref>G,H shows that cytokine-induced caspase-3 cleavage was reduced by &#x0223c;50% in the <italic>siClic4</italic>-transfected cells as compared with <italic>siCT</italic>-transfected cells and this cleavage was still significantly reduced by exendin-4.</p><p>Collectively, these data showed that Clic4 expression is induced by cytokines and sensitizes &#x003b2;TC-tet cells to cytokine-induced apoptosis. In addition, the anti-apoptotic effect of GLP-1 is still present upon <italic>Clic4</italic> silencing indicating that GLP-1 signaling is independent of Clic4 expression.</p><p>To determine whether Clic4 is required for the normal control of glucose-stimulated insulin secretion, we silenced Clic4 in &#x003b2;TC-tet cells and in Min6B1 cells and exposed the cells to 2 or 20&#x000a0;mM glucose and in the presence and absence of exendin-4. As shown in <xref rid="fig1" ref-type="fig">Figure&#x000a0;1</xref>I,J Clic4 silencing did not impact glucose stimulated insulin secretion.</p></sec><sec id="sec3.2"><label>3.2</label><title><italic>Clic4</italic> silencing increases Bcl-2 and Bad expression as well as Bad phosphorylation</title><p>Cytokines induce &#x003b2;-cell apoptosis mainly through activation of the mitochondrial apoptotic pathway, which involves the participation of anti- and pro-apoptotic Bcl2-family proteins <xref rid="bib17" ref-type="bibr">[17]</xref>. We thus examined whether <italic>Clic4</italic> silencing would modulate expression of Bcl-2, Bcl-xL and Bad. Here, <italic>siCT</italic>- or <italic>siClic4</italic>-transfected &#x003b2;TC-tet cells were treated or not with cytokines for 15&#x000a0;h. Quantitative RT-PCR analysis showed no difference in <italic>Bcl2</italic>, <italic>Bad</italic> and <italic>Bcl-xL</italic> mRNA expression in <italic>siCT</italic> or <italic>siClic4</italic> transfected cells and no change in response to cytokine treatment (data not shown). However, western blot analysis of whole cell lysates showed that silencing <italic>Clic4</italic> increased expression of Bcl-2 (&#x0223c;2-fold), Bad (&#x0223c;1.4 fold), of phosphorylated Bad (pBad) (&#x0223c;2 fold), and of the pBad/Bad ratio (<xref rid="fig2" ref-type="fig">Figure&#x000a0;2</xref>B&#x02013;E). <italic>Clic4</italic> silencing did not affect Bcl-xL protein expression under basal conditions or after cytokine treatment (<xref rid="fig2" ref-type="fig">Figure&#x000a0;2</xref>F) and only slightly decreased Bax protein expression after cytokine treatment (<xref rid="fig2" ref-type="fig">Figure&#x000a0;2</xref>G).</p></sec><sec id="sec3.3"><label>3.3</label><title><italic>Clic4</italic> silencing did not affect expression of PUMA, Bim<sub>s</sub>, Bim<sub>L</sub>, Bim<sub>xL</sub> and phosphorylation of Bim and JNK in <bold>&#x003b2;</bold>TC-tet cells</title><p>We next examined expression of the pro-apoptotic members of the Bcl-2 family, PUMA and Bim. It has been shown that JNK-induced Bim phosphorylation on serine 65 contributes to &#x003b2;-cell apoptosis <xref rid="bib44" ref-type="bibr">[44]</xref>. Moreover Bim has three main isoforms generated by alternative splicing, namely Bim<sub>EL</sub>, Bim<sub>L</sub> and the most pro-apoptotic variant Bim<sub>s</sub>
<xref rid="bib45" ref-type="bibr">[45]</xref>. Hence we examined protein expression of all three variants of Bim, phosphorylated Bim, JNK activation and PUMA in <italic>siCT</italic>- or <italic>siClic4</italic>-transfected &#x003b2;TC-tet cells treated or not with cytokines for 15&#x000a0;h. The western blot of <xref rid="fig3" ref-type="fig">Figure&#x000a0;3</xref>A-G, shows that <italic>Clic4</italic> silencing did not affect the expression level of PUMA, the three variants of Bim, or the phosphorylation state of JNK or Bim.</p><p>Thus, <italic>Clic4</italic> silencing reduces cytokines-induced apoptosis was correlated with increased expression of the anti-apoptotic proteins Bcl-2, Bad, and increased phosphorylation of Bad (<xref rid="fig2" ref-type="fig">Figure&#x000a0;2</xref>).</p></sec><sec id="sec3.4"><label>3.4</label><title>Clic4 knockdown increases the half-life of Bcl-2 and Bad</title><p>To determine whether <italic>Clic4</italic> silencing could increase Bcl-2 and Bad stability, <italic>siCT</italic>- or si<italic>Clic4</italic>-transfected &#x003b2;TC-tet cells were treated with cycloheximide for different periods of time and the level of expression of both proteins was assessed by western blot analysis. The rate of protein degradation was expressed as log of the percentage of initial value at t&#x000a0;=&#x000a0;0 and protein half-life (t<sub>1/2</sub>) was measured by regression analysis. <italic>Clic4</italic> silencing increased Blc2 and Bad half-lives (<xref rid="fig4" ref-type="fig">Figure&#x000a0;4</xref>A&#x02013;C) from &#x0223c;29&#x000a0;h&#x000a0;to &#x0223c;66&#x000a0;h&#x000a0;for Bcl2, and from &#x0223c;16&#x000a0;h&#x000a0;to &#x0223c;28&#x000a0;h&#x000a0;for Bad.</p></sec><sec id="sec3.5"><label>3.5</label><title>Generation of <bold>&#x003b2;</bold>-cell specific <italic>Clic4</italic> conditional knockout (<bold><italic>&#x003b2;</italic></bold><italic>Clic4KO</italic>) mice</title><p>To study the role of Clic4 in primary &#x003b2;-cells, we generated mice with &#x003b2;-cell-specific inactivation of <italic>Clic4</italic>. <xref rid="fig5" ref-type="fig">Figure&#x000a0;5</xref>A shows the recombination strategy in which exon 2 of the <italic>Clic4</italic> gene was flanked by loxP sites by homologous recombination in embryonic stem cells. <italic>Clic4</italic><sup><italic>lox/lox</italic></sup> mice were crossed with <italic>Ins1</italic><sup><italic>Cre</italic></sup> mice <xref rid="bib38" ref-type="bibr">[38]</xref>, which ensure complete and &#x003b2;-cell-selective floxed gene recombination, in order to obtain <italic>Clic4</italic>
<sup><italic>lox/lox</italic></sup>;<italic>Ins1</italic><sup><italic>Cre</italic>/+</sup> (<italic>&#x003b2;Clic4KO</italic>) and <italic>Clic4</italic>
<sup><italic>lox/lox</italic></sup>;<italic>Ins1</italic><sup>+/+</sup> (Control) mice. Selective recombination in the islets was confirmed by PCR analysis of recombined alleles (<xref rid="fig5" ref-type="fig">Figure&#x000a0;5</xref>B); this led to &#x0223c;85% reduction in <italic>Clic4</italic> gene expression in <italic>&#x003b2;Clic4KO</italic> mouse islets (<xref rid="fig5" ref-type="fig">Figure&#x000a0;5</xref>C), consistent with Clic4 inactivation in all &#x003b2;-cells.</p><p>To assess whether inactivation of <italic>Clic4</italic> in &#x003b2;-cells would impact glucose homeostasis, we generated cohorts of male and female control and <italic>&#x003b2;Clic4KO</italic> mice and fed them a normal chow for 18 weeks, or a high fat diet for 12 weeks starting at 6 weeks of age. No difference in glucose tolerance nor in insulin secretion could be observed between Control and <italic>&#x003b2;Clic4KO</italic> mice following intraperitoneal glucose injections, nor any difference in &#x003b2;-cell mass (not shown).</p></sec><sec id="sec3.6"><label>3.6</label><title>Islet <bold>&#x003b2;</bold>-cells from <bold><italic>&#x003b2;</italic></bold><italic>Clic4KO</italic> mice are less sensitive to induced apoptosis</title><p>Islets from control and <italic>&#x003b2;Clic4KO</italic> mice were cultured on extracellular-coated Petri dishes to induce monolayer formation. Cells were then exposed to cytokines for 15&#x000a0;h&#x000a0;with or without a 9&#x000a0;h&#x000a0;pretreatment with exendin-4. Apoptosis was then measured by TUNEL assay. <xref rid="fig5" ref-type="fig">Figure&#x000a0;5</xref>D shows that cytokines induced apoptosis in &#x0223c;7% of control islet cells and &#x0223c;4% of <italic>&#x003b2;Clic4KO</italic> islets. Exendin-4 significantly reduced cytokine-induced apoptosis in both types of islets. Similarly, palmitic acid-induced apoptosis was lower in <italic>&#x003b2;Clic4KO</italic> &#x003b2;-cells and exendin-4 also reduced apoptosis in both types of islets (<xref rid="fig5" ref-type="fig">Figure&#x000a0;5</xref>E). Thus, Clic4 is also a pro-apoptotic protein in primary islet cells. Note that we did not specifically measure apoptosis in &#x003b2;-cells but rather in the whole islet cell population, but the use of <italic>Ins1</italic><sup><italic>Cre</italic></sup> mice ensures that <italic>Clic4</italic> is inactivated only in &#x003b2;-cells <xref rid="bib38" ref-type="bibr">[38]</xref>.</p></sec><sec id="sec3.7"><label>3.7</label><title>Islets from <bold><italic>&#x003b2;</italic></bold><italic>Clic4KO</italic> mice have increased expression of Bcl2, Bcl-xL, Bad, and pBad</title><p>We next evaluated <italic>Bcl-2</italic>, <italic>Bad</italic> and <italic>Bcl-xL</italic> mRNA expression in islets from <italic>&#x003b2;Clic4KO</italic> and control mice exposed or not to cytokines for 15&#x000a0;h. <xref rid="fig6" ref-type="fig">Figure&#x000a0;6</xref>A shows that <italic>Clic4</italic> mRNA expression was increased by &#x0223c;9-fold after cytokine treatment in control islets; <italic>Bcl-2</italic> mRNA expression was increased by 50% in islets from <italic>&#x003b2;Clic4KO</italic> mice in the absence of treatment but was not different after cytokine treatment (<xref rid="fig6" ref-type="fig">Figure&#x000a0;6</xref>B); <italic>Bad</italic> mRNA expression was increased by &#x0223c;30% in islets from <italic>&#x003b2;Clic4KO</italic> mice under basal conditions and following cytokines treatment (<xref rid="fig6" ref-type="fig">Figure&#x000a0;6</xref>C) and <italic>Bcl-xL</italic> mRNA level was not significantly different in islets from <italic>&#x003b2;Clic4KO</italic> or control mice under basal conditions or following cytokine treatment (<xref rid="fig6" ref-type="fig">Figure&#x000a0;6</xref>D).</p><p>Western blot analysis of islets from control and <italic>&#x003b2;Clic4KO</italic> mice, treated or not with cytokines for 15&#x000a0;h, showed an &#x0223c;2-fold increased expression of Bcl-2 in the islets from <italic>&#x003b2;Clic4KO</italic> mice as compared to control islets, both in the presence or absence of cytokines. Total Bad expression and the level of phosphorylated Bad were also increased in <italic>&#x003b2;Clic4KO</italic> mouse islets and the ratio of pBad to total Bad was increased by &#x0223c;75% in basal conditions and &#x0223c;60% after cytokines treatment (<xref rid="fig6" ref-type="fig">Figure&#x000a0;6</xref>H). Bcl-xL expression was higher by &#x0223c;77% in islets from <italic>&#x003b2;Clic4KO</italic> mice as compared with islet from control mice; this difference no longer reached significance after cytokine treatment (<xref rid="fig6" ref-type="fig">Figure&#x000a0;6</xref>J).</p></sec><sec id="sec3.8"><label>3.8</label><title>Mass-spectrometry analysis of proteins associated with Clic4</title><p>Because the above data indicated higher level and stability of Bcl2, Bad and pBad in the absence of Clic4, we wondered whether this could be due to the suppression of a direct interaction of Clic4 with these proteins. We therefore immunoprecipitated Clic4 from &#x003b2;TC-tet cells using antibodies directed against the C- or N-terminal ends of the protein and subjected the immunoprecipitates to western blot and LC&#x02013;MS/MS analysis. <xref rid="fig7" ref-type="fig">Figure&#x000a0;7</xref>A shows that Clic4 antibodies efficiently immunoprecipitated Clic4 and that neither Bcl2 nor Bad co-immunoprecipitated with Clic4. The co-immunoprecipitates were then separated by gel electrophoresis (<xref rid="fig7" ref-type="fig">Figure&#x000a0;7</xref>B) and the individual lanes were cut in small segments for trypsin digestion and mass spectrometry analysis. We identified 78 proteins that were selectively enriched in the Clic4 co-immunoprecipitates as compared with the control IgG co-immunoprecipitate. Sixty-six proteins were co-immunoprecipitated with the C-terminal antibody, 10 with the N-terminal antibody, and two with both antibodies (<xref rid="tbl1" ref-type="table">Table&#x000a0;1</xref>). The proteins were grouped according to their biological or cellular functions (<xref rid="tbl1" ref-type="table">Table&#x000a0;1</xref>), showing that they pertain to diverse cellular processes such as proteasomal degradation, protein biosynthesis, cell cycle, kinase/phosphatases, apoptosis, protein transport and regulator of GTPase activity.</p></sec></sec><sec sec-type="discussion" id="sec4"><label>4</label><title>Discussion</title><p>The present study shows that <italic>Clic4</italic> is a cytokine-induced gene in pancreatic &#x003b2;-cells, and that silencing its expression in &#x003b2;TC-tet cells or inactivating its gene in primary &#x003b2;-cells markedly reduces cytokines-induced apoptosis. &#x003b2;-cells from <italic>&#x003b2;Clic4KO</italic> mice were also more resistant to lipotoxicity, suggesting a role for Clic4 also in ER-stress mediated apoptosis. Suppressing Clic4 expression leads to increased stability of Bcl-2 and Bad and increased levels of pBad. Liquid chromatography&#x02013;MS/MS analysis revealed that Clic4 does not directly interact with Bcl2 family proteins, while it interacts with components of the proteasome and other protein classes. Thus, Clic4 is a newly described &#x003b2;-cell pro-apoptotic gene that regulates the half-lives of Bcl-2 family proteins through an indirect mechanism, possibly involving proteasome action.</p><p>Cytokines induce &#x003b2;-cell apoptosis mainly through activation of the mitochondrial apoptotic pathway, which involves regulated expression of anti- and pro-apoptotic Bcl2-family proteins and their differential interactions eventually leading to induction of mitochondrial permeability, cytochrome c release, and activation of caspase 3 <xref rid="bib17" ref-type="bibr">[17]</xref>. Here, we showed that <italic>Clic4</italic> knockdown in &#x003b2;TC-tet cells or genetic inactivation in islets &#x003b2;-cells increased expression of the anti-apoptotic proteins Bcl-2, Bcl-xL, and led to increased phosphorylation of Bad, which inhibits its pro-apoptotic activity. Increased expression of these proteins was independent from changes in their mRNA levels, indicating a regulation at the translational or posttranslational level. Analysis of protein stability showed that the half-lives of Bcl-2 and Bad were indeed markedly prolonged in the absence of Clic4. Mass spectrometry analysis of the Clic4-interacting proteins did not reveal any interactions with Bcl2 family proteins suggesting that Clic4 has an indirect role on Bcl2 and Bad stability. This analysis, however, revealed interactions of Clic4 with several proteins involved in proteosomal degradation, suggesting that Clic4 may regulate the rate of Bcl2 family proteins degradation through proteasomal activity. We attempted to determine whether blocking proteasomal activity with a specific inhibitor, MG132, would impact the stability of Bcl2 or Bad in the presence or absence of Clic4. However, MG132 treatment was toxic for &#x003b2;TC-tet cells leading to their death already 12&#x000a0;h&#x000a0;after beginning of the treatment. This prevented analysis of the impact of blocking proteasome activity on Bcl-2 and Bad because their half-lives are greater than 20&#x000a0;h. Whether absence of Clic4 has a role in the control of Bad and Bcl2 biosynthesis is not yet known.</p><p>Clic4 also sensitizes &#x003b2;-cells to palmitic-acid induced apoptosis, a process associated with increased expression of ER stress markers <xref rid="bib46 bib47" ref-type="bibr">[46,47]</xref>. In &#x003b2;TC-tet cells, thapsigargin-induced ER stress increased the expression of the ER stress markers genes Chop, Atf4, Gadd34, Atf6, Bip, and the spliced form of Xbp1 to the same extent in control or <italic>Clic4</italic>-silenced cells (data not shown). Thus, the protection against lipotoxicity conferred by Clic4 silencing is unlikely due to repression of ER stress markers but may depend on the increased stability of Bcl-2, Bcl-xL and pBad.</p><p>Mass spectrometry analysis of Clic4 immunoprecipitates revealed that Clic4 binds to proteins involved in several cellular process or functions, including protein biosynthesis, cell-cycle, apoptosis, protein degradation, protein transport, and kinases or phosphatases. These data suggest that Clic4 may affect cell survival through different mechanisms, possibly in a context dependent manner.</p><p>Finally, CLIC4 is also well expressed in human islets (Median RPKM 23, RNASeq data <xref rid="bib48" ref-type="bibr">[48]</xref>), and there is a 1.7-fold increase in its expression following a 48&#x000a0;h exposure to cytokines while there is no clear change in expression following 48&#x000a0;h palmitate exposure (Median RPKM 26; <italic>n</italic>&#x000a0;=&#x000a0;5 <xref rid="bib49" ref-type="bibr">[49]</xref>). CLIC4 is also well expressed in FACS-purified rat beta cells, with a 5&#x02013;7-fold increase in expression after 6 or 24&#x000a0;h exposure to IL-1&#x000a0;+&#x000a0;IFN&#x003b3; or TNF&#x000a0;+&#x000a0;IFN&#x003b3; <xref rid="bib50" ref-type="bibr">[50]</xref>. It is conceivable that we did not see a more marked increase in CLIC4 expression human islets due to the late time of study.</p><p>Collectively, our data show that Clic4 sensitizes &#x003b2;-cells to cytokines- or palmitic acid-induced apoptosis. Reducing Clic4 expression increases &#x003b2;-cell survival, an event associated with, and likely caused by, the increased stability and cellular expression levels of Bcl-2, Bcl-xL and of the phosphorylated form of Bad. It is indeed known that Bcl-2 or Bcl-xL overexpression in &#x003b2;-cells increases their resistance to cytokine-induced apoptosis <xref rid="bib51 bib52 bib53" ref-type="bibr">[51&#x02013;53]</xref>. Thus, targeting Clic4 expression or its interaction with specific protein partners identified in our mass spectrometry analysis may provide a new way to prevent &#x003b2;-cell apoptosis in the context of diabetes mellitus.</p></sec></body><back><ref-list><title>References</title><ref id="bib1"><label>1</label><element-citation publication-type="journal" id="sref1"><person-group person-group-type="author"><name><surname>Eizirik</surname><given-names>D.L.</given-names></name><name><surname>Colli</surname><given-names>M.L.</given-names></name><name><surname>Ortis</surname><given-names>F.</given-names></name></person-group><article-title>The role of inflammation in insulitis and &#x003b2;-cell loss in type 1 diabetes</article-title><source>Nature Reviews Endocrinology</source><volume>5</volume><year>2009</year><fpage>219</fpage><lpage>226</lpage></element-citation></ref><ref id="bib2"><label>2</label><element-citation publication-type="journal" id="sref2"><person-group person-group-type="author"><name><surname>Butler</surname><given-names>A.E.</given-names></name><name><surname>Janson</surname><given-names>J.</given-names></name><name><surname>Bonner-Weir</surname><given-names>S.</given-names></name><name><surname>Ritzel</surname><given-names>R.</given-names></name><name><surname>Rizza</surname><given-names>R.A.</given-names></name><name><surname>Butler</surname><given-names>P.C.</given-names></name></person-group><article-title>&#x003b2;-cell deficit and increased &#x003b2;-cell apoptosis in humans with type 2 diabetes</article-title><source>Diabetes</source><volume>52</volume><year>2003</year><fpage>102</fpage><lpage>110</lpage><pub-id pub-id-type="pmid">12502499</pub-id></element-citation></ref><ref id="bib3"><label>3</label><element-citation publication-type="journal" id="sref3"><person-group person-group-type="author"><name><surname>Mathis</surname><given-names>D.</given-names></name><name><surname>Vence</surname><given-names>L.</given-names></name><name><surname>Benoist</surname><given-names>C.</given-names></name></person-group><article-title>&#x003b2;-cell death during progression to diabetes</article-title><source>Nature</source><volume>414</volume><year>2001</year><fpage>792</fpage><lpage>798</lpage><pub-id pub-id-type="pmid">11742411</pub-id></element-citation></ref><ref id="bib4"><label>4</label><element-citation publication-type="journal" id="sref4"><person-group person-group-type="author"><name><surname>Eizirik</surname><given-names>D.L.</given-names></name><name><surname>Mandrup-Poulsen</surname><given-names>T.</given-names></name></person-group><article-title>A&#x000a0;choice of death&#x02013;the signal-transduction of immune-mediated b-cell apoptosis</article-title><source>Diabetologia</source><volume>44</volume><year>2001</year><fpage>2115</fpage><lpage>2133</lpage><pub-id pub-id-type="pmid">11793013</pub-id></element-citation></ref><ref id="bib5"><label>5</label><element-citation publication-type="journal" id="sref5"><person-group person-group-type="author"><name><surname>Thomas</surname><given-names>H.E.</given-names></name><name><surname>McKenzie</surname><given-names>M.D.</given-names></name><name><surname>Angstetra</surname><given-names>E.</given-names></name><name><surname>Campbell</surname><given-names>P.D.</given-names></name><name><surname>Kay</surname><given-names>T.W.</given-names></name></person-group><article-title>Beta cell apoptosis in diabetes</article-title><source>Apoptosis</source><volume>14</volume><year>2009</year><fpage>1389</fpage><lpage>1404</lpage><pub-id pub-id-type="pmid">19322660</pub-id></element-citation></ref><ref id="bib6"><label>6</label><element-citation publication-type="journal" id="sref6"><person-group person-group-type="author"><name><surname>Ehses</surname><given-names>J.A.</given-names></name><name><surname>Perren</surname><given-names>A.</given-names></name><name><surname>Eppler</surname><given-names>E.</given-names></name><name><surname>Ribaux</surname><given-names>P.</given-names></name><name><surname>Pospisilik</surname><given-names>J.A.</given-names></name><name><surname>Maor-Cahn</surname><given-names>R.</given-names></name></person-group><article-title>Increased number of islet-associated macrophages in type 2 diabetes</article-title><source>Diabetes</source><volume>56</volume><issue>9</issue><year>2007</year><fpage>2356</fpage><lpage>2370</lpage><pub-id pub-id-type="pmid">17579207</pub-id></element-citation></ref><ref id="bib7"><label>7</label><element-citation publication-type="journal" id="sref7"><person-group person-group-type="author"><name><surname>Maedler</surname><given-names>K.</given-names></name><name><surname>Sergeev</surname><given-names>P.</given-names></name><name><surname>Ris</surname><given-names>F.</given-names></name><name><surname>Oberholzer</surname><given-names>J.</given-names></name><name><surname>Joller-Jemelka</surname><given-names>H.I.</given-names></name><name><surname>Spinas</surname><given-names>G.A.</given-names></name></person-group><article-title>Glucose-induced beta-cell production of interleukin-1beta contributes to glucotoxicity in human pancreatic islets</article-title><source>Journal of Clinical Investigation</source><volume>110</volume><year>2002</year><fpage>851</fpage><lpage>860</lpage><pub-id pub-id-type="pmid">12235117</pub-id></element-citation></ref><ref id="bib8"><label>8</label><element-citation publication-type="journal" id="sref8"><person-group person-group-type="author"><name><surname>Igoillo-Esteve</surname><given-names>M.</given-names></name><name><surname>Marselli</surname><given-names>L.</given-names></name><name><surname>Cunha</surname><given-names>D.A.</given-names></name><name><surname>Ladri&#x000e8;re</surname><given-names>L.</given-names></name><name><surname>Ortis</surname><given-names>F.</given-names></name><name><surname>Grieco</surname><given-names>F.A.</given-names></name></person-group><article-title>Palmitate induces a pro-inflammatory response in human pancreatic islets that mimics CCL2 expression by beta cells in type 2 diabetes</article-title><source>Diabetologia</source><volume>53</volume><issue>7</issue><year>2010</year><fpage>1395</fpage><lpage>1405</lpage><pub-id pub-id-type="pmid">20369226</pub-id></element-citation></ref><ref id="bib9"><label>9</label><element-citation publication-type="journal" id="sref9"><person-group person-group-type="author"><name><surname>Rhodes</surname><given-names>C.J.</given-names></name></person-group><article-title>Type 2 diabetes-a matter of &#x003b2;-cell life and death?</article-title><source>Science</source><volume>307</volume><year>2005</year><fpage>380</fpage><lpage>384</lpage><pub-id pub-id-type="pmid">15662003</pub-id></element-citation></ref><ref id="bib10"><label>10</label><element-citation publication-type="journal" id="sref10"><person-group person-group-type="author"><name><surname>Eizirik</surname><given-names>D.L.</given-names></name><name><surname>Cardozo</surname><given-names>A.K.</given-names></name><name><surname>Cnop</surname><given-names>M.</given-names></name></person-group><article-title>The role for endoplasmic reticulum stress in diabetes mellitus</article-title><source>Endocrine Reviews</source><volume>29</volume><year>2008</year><fpage>42</fpage><lpage>61</lpage><pub-id pub-id-type="pmid">18048764</pub-id></element-citation></ref><ref id="bib11"><label>11</label><element-citation publication-type="journal" id="sref11"><person-group person-group-type="author"><name><surname>Donath</surname><given-names>M.Y.</given-names></name><name><surname>Gross</surname><given-names>D.J.</given-names></name><name><surname>Cerasi</surname><given-names>E.</given-names></name><name><surname>Kaiser</surname><given-names>N.</given-names></name></person-group><article-title>Hyperglycemia-induced beta-cell apoptosis in pancreatic islets of Psammomys obesus during development of diabetes</article-title><source>Diabetes</source><volume>48</volume><year>1999</year><fpage>738</fpage><lpage>744</lpage><pub-id pub-id-type="pmid">10102689</pub-id></element-citation></ref><ref id="bib12"><label>12</label><element-citation publication-type="journal" id="sref12"><person-group person-group-type="author"><name><surname>Gremlich</surname><given-names>S.</given-names></name><name><surname>Bonny</surname><given-names>C.</given-names></name><name><surname>Waeber</surname><given-names>G.</given-names></name><name><surname>Thorens</surname><given-names>B.</given-names></name></person-group><article-title>Fatty acids decrease IDX-1 expression in rat pancreatic islets and reduce GLUT2, glucokinase, insulin, and somatostatin levels</article-title><source>Journal of Biological Chemistry</source><volume>272</volume><year>1997</year><fpage>30261</fpage><lpage>30269</lpage><pub-id pub-id-type="pmid">9374511</pub-id></element-citation></ref><ref id="bib13"><label>13</label><element-citation publication-type="journal" id="sref13"><person-group person-group-type="author"><name><surname>Donath</surname><given-names>M.Y.</given-names></name><name><surname>Dalmas</surname><given-names>&#x000c9;.</given-names></name><name><surname>Sauter</surname><given-names>N.S.</given-names></name><name><surname>B&#x000f6;ni-Schnetzler</surname><given-names>M.</given-names></name></person-group><article-title>Inflammation in obesity and diabetes: islet dysfunction and therapeutic opportunity</article-title><source>Cell Metabolism</source><volume>17</volume><issue>6</issue><year>2013</year><fpage>860</fpage><lpage>872</lpage><pub-id pub-id-type="pmid">23747245</pub-id></element-citation></ref><ref id="bib14"><label>14</label><element-citation publication-type="journal" id="sref14"><person-group person-group-type="author"><name><surname>Cardozo</surname><given-names>A.K.</given-names></name><name><surname>Heimberg</surname><given-names>H.</given-names></name><name><surname>Heremans</surname><given-names>Y.</given-names></name><name><surname>Leeman</surname><given-names>R.</given-names></name><name><surname>Kutlu</surname><given-names>B.</given-names></name><name><surname>Kruh&#x000f8;ffer</surname><given-names>M.</given-names></name></person-group><article-title>A&#x000a0;comprehensive analysis of cytokine induced and nuclear factor-kB-dependent genes in primary rat pancreatic b-cells</article-title><source>Journal of Biological Chemistry</source><volume>276</volume><year>2001</year><fpage>48879</fpage><lpage>48886</lpage><pub-id pub-id-type="pmid">11687580</pub-id></element-citation></ref><ref id="bib15"><label>15</label><element-citation publication-type="journal" id="sref15"><person-group person-group-type="author"><name><surname>Moore</surname><given-names>F.</given-names></name><name><surname>Naamane</surname><given-names>N.</given-names></name><name><surname>Colli</surname><given-names>M.L.</given-names></name><name><surname>Bouckenooghe</surname><given-names>T.</given-names></name><name><surname>Ortis</surname><given-names>F.</given-names></name><name><surname>Gurzov</surname><given-names>E.N.</given-names></name></person-group><article-title>STAT1 is a master regulator of pancreatic beta cells apoptosis and islet inflammation</article-title><source>Journal of Biological Chemistry</source><volume>286</volume><year>2011</year><fpage>929</fpage><lpage>941</lpage><pub-id pub-id-type="pmid">20980260</pub-id></element-citation></ref><ref id="bib16"><label>16</label><element-citation publication-type="journal" id="sref16"><person-group person-group-type="author"><name><surname>Donath</surname><given-names>M.Y.</given-names></name><name><surname>Storling</surname><given-names>J.</given-names></name><name><surname>Maedler</surname><given-names>K.</given-names></name><name><surname>Mandrup-Poulsen</surname><given-names>T.</given-names></name></person-group><article-title>Inflammatory mediators and islet beta-cell failure: a link between type 1 and type 2 diabetes</article-title><source>Journal of Molecular Medicine (Berlin)</source><volume>81</volume><year>2003</year><fpage>455</fpage><lpage>470</lpage></element-citation></ref><ref id="bib17"><label>17</label><element-citation publication-type="journal" id="sref17"><person-group person-group-type="author"><name><surname>Gurzov</surname><given-names>E.N.</given-names></name><name><surname>Eizirik</surname><given-names>D.L.</given-names></name></person-group><article-title>Bcl-2 proteins in diabetes: mitochondrial pathways of &#x003b2;-cell death and dysfunction</article-title><source>Trends in Cell Biology</source><volume>21</volume><issue>No. 27</issue><year>2011</year></element-citation></ref><ref id="bib18"><label>18</label><element-citation publication-type="journal" id="sref18"><person-group person-group-type="author"><name><surname>Kim</surname><given-names>H.</given-names></name><name><surname>Rafiuddin-Shah</surname><given-names>M.</given-names></name><name><surname>Tu</surname><given-names>H.C.</given-names></name><name><surname>Jeffers</surname><given-names>J.R.</given-names></name><name><surname>Zambetti</surname><given-names>G.P.</given-names></name><name><surname>Hsieh</surname><given-names>J.J.</given-names></name></person-group><article-title>Hierarchical regulation of mitochondrion-dependent apoptosis by BCL-2 subfamilies</article-title><source>Nature Cell Biology</source><volume>8</volume><year>2006</year><fpage>1348</fpage><lpage>1358</lpage></element-citation></ref><ref id="bib19"><label>19</label><element-citation publication-type="journal" id="sref19"><person-group person-group-type="author"><name><surname>Gross</surname><given-names>A.</given-names></name><name><surname>Jockel</surname><given-names>J.</given-names></name><name><surname>Wei</surname><given-names>M.C.</given-names></name><name><surname>Korsmeyer</surname><given-names>S.J.</given-names></name></person-group><article-title>Enforced dimerization of BAX results in its translocation, mitochondrial dysfunction and apoptosis</article-title><source>EMBO Journal</source><volume>17</volume><year>1998</year><fpage>3878</fpage><lpage>3885</lpage><pub-id pub-id-type="pmid">9670005</pub-id></element-citation></ref><ref id="bib20"><label>20</label><element-citation publication-type="journal" id="sref20"><person-group person-group-type="author"><name><surname>Kim</surname><given-names>H.</given-names></name><name><surname>Tu</surname><given-names>H.C.</given-names></name><name><surname>Ren</surname><given-names>D.</given-names></name><name><surname>Takeuchi</surname><given-names>O.</given-names></name><name><surname>Jeffers</surname><given-names>J.R.</given-names></name><name><surname>Zambetti</surname><given-names>G.P.</given-names></name></person-group><article-title>Stepwise activation of BAX and BAK by tBID BIM, and PUMA initiates mitochondrial apoptosis</article-title><source>Molecular Cell</source><volume>36</volume><year>2009</year><fpage>487</fpage><lpage>499</lpage><pub-id pub-id-type="pmid">19917256</pub-id></element-citation></ref><ref id="bib21"><label>21</label><element-citation publication-type="journal" id="sref21"><person-group person-group-type="author"><name><surname>Tait</surname><given-names>S.W.</given-names></name><name><surname>Green</surname><given-names>D.R.</given-names></name></person-group><article-title>Mitochondria and cell death: outer membrane permeabilization and beyond</article-title><source>Nature Reviews Molecular Cell Biology</source><volume>11</volume><year>2010</year><fpage>621</fpage><lpage>632</lpage></element-citation></ref><ref id="bib22"><label>22</label><element-citation publication-type="journal" id="sref22"><person-group person-group-type="author"><name><surname>Zhang</surname><given-names>D.</given-names></name><name><surname>Armstrong</surname><given-names>J.S.</given-names></name></person-group><article-title>Bax and the mitochondrial permeability transition cooperate in the release of cytochrome c during endoplasmic reticulum-stress-induced apoptosis</article-title><source>Cell Death and Differentiation</source><volume>14</volume><year>2007</year><fpage>703</fpage><lpage>715</lpage><pub-id pub-id-type="pmid">17170750</pub-id></element-citation></ref><ref id="bib23"><label>23</label><element-citation publication-type="journal" id="sref23"><person-group person-group-type="author"><name><surname>Hacki</surname><given-names>J.</given-names></name><name><surname>Egger</surname><given-names>L.</given-names></name><name><surname>Monney</surname><given-names>L.</given-names></name><name><surname>Conus</surname><given-names>S.</given-names></name><name><surname>Rosse</surname><given-names>T.</given-names></name><name><surname>Fellay</surname><given-names>I.</given-names></name></person-group><article-title>Apoptotic crosstalk between the endoplasmic reticulum and mitochondria controlled by Bcl-2</article-title><source>Oncogene</source><volume>19</volume><year>2000</year><fpage>2286</fpage><lpage>2295</lpage><pub-id pub-id-type="pmid">10822379</pub-id></element-citation></ref><ref id="bib24"><label>24</label><element-citation publication-type="journal" id="sref24"><person-group person-group-type="author"><name><surname>Duncan</surname><given-names>R.R.</given-names></name><name><surname>Westwood</surname><given-names>P.K.</given-names></name><name><surname>Boyd</surname><given-names>A.</given-names></name><name><surname>Ashley</surname><given-names>R.H.</given-names></name></person-group><article-title>Rat brain p64H1, expression of a new member of the p64 chloride channel protein family in endoplasmic reticulum</article-title><source>Journal of Biological Chemistry</source><volume>272</volume><year>1997</year><fpage>23880</fpage><lpage>23886</lpage><pub-id pub-id-type="pmid">9295337</pub-id></element-citation></ref><ref id="bib25"><label>25</label><element-citation publication-type="journal" id="sref25"><person-group person-group-type="author"><name><surname>Howell</surname><given-names>S.</given-names></name><name><surname>Duncan</surname><given-names>R.R.</given-names></name><name><surname>Ashley</surname><given-names>R.H.</given-names></name></person-group><article-title>Identification and characterization of a homologue of p64 in rat tissues</article-title><source>FEBS Letters</source><volume>390</volume><year>1996</year><fpage>207</fpage><lpage>210</lpage><pub-id pub-id-type="pmid">8706861</pub-id></element-citation></ref><ref id="bib26"><label>26</label><element-citation publication-type="journal" id="sref26"><person-group person-group-type="author"><name><surname>Littler</surname><given-names>D.R.</given-names></name><name><surname>Harrop</surname><given-names>S.J.</given-names></name><name><surname>Goodchild</surname><given-names>S.C.</given-names></name><name><surname>Phang</surname><given-names>J.M.</given-names></name><name><surname>Mynott</surname><given-names>A.V.</given-names></name><name><surname>Jiang</surname><given-names>L.</given-names></name></person-group><article-title>The enigma of the CLIC proteins: ion channels, redox proteins, enzymes, scaffolding proteins?</article-title><source>FEBS Letters</source><volume>584</volume><year>2010</year><fpage>2093</fpage><lpage>2101</lpage><pub-id pub-id-type="pmid">20085760</pub-id></element-citation></ref><ref id="bib27"><label>27</label><element-citation publication-type="journal" id="sref27"><person-group person-group-type="author"><name><surname>Suh</surname><given-names>K.S.</given-names></name><name><surname>Mutoh</surname><given-names>M.</given-names></name><name><surname>Gerdes</surname><given-names>M.</given-names></name><name><surname>Yuspa</surname><given-names>S.H.</given-names></name></person-group><article-title>CLIC4, an intracellular chloride channel protein, is a novel molecular target for cancer therapy</article-title><source>Journal of Investigative Dermatology Symposium Proceedings</source><volume>10</volume><year>2005</year><fpage>105</fpage><lpage>109</lpage></element-citation></ref><ref id="bib28"><label>28</label><element-citation publication-type="journal" id="sref28"><person-group person-group-type="author"><name><surname>Bohman</surname><given-names>S.</given-names></name><name><surname>Matsumoto</surname><given-names>T.</given-names></name><name><surname>Suh</surname><given-names>K.</given-names></name><name><surname>Dimberg</surname><given-names>A.</given-names></name><name><surname>Jakobsson</surname><given-names>L.</given-names></name><name><surname>Yuspa</surname><given-names>S.</given-names></name></person-group><article-title>Proteomic analysis of vascular endothelial growth factor-induced endothelial cell differentiation reveals a role for chloride intracellular channel 4 (CLIC4) in tubular morphogenesis</article-title><source>Journal of Biological Chemistry</source><volume>280</volume><year>2005</year><fpage>42397</fpage><lpage>42404</lpage><pub-id pub-id-type="pmid">16239224</pub-id></element-citation></ref><ref id="bib29"><label>29</label><element-citation publication-type="journal" id="sref29"><person-group person-group-type="author"><name><surname>Tung</surname><given-names>J.J.</given-names></name><name><surname>Hobert</surname><given-names>O.</given-names></name><name><surname>Berryman</surname><given-names>M.</given-names></name><name><surname>Kitajewski</surname><given-names>J.</given-names></name></person-group><article-title>Chloride intracellular channel 4 is involved in endothelial proliferation and morphogenesis in&#x000a0;vitro</article-title><source>Angiogenesis</source><volume>12</volume><year>2009</year><fpage>209</fpage><lpage>220</lpage><pub-id pub-id-type="pmid">19247789</pub-id></element-citation></ref><ref id="bib30"><label>30</label><element-citation publication-type="journal" id="sref30"><person-group person-group-type="author"><name><surname>Ronnov-Jessen</surname><given-names>L.</given-names></name><name><surname>Villadsen</surname><given-names>R.</given-names></name><name><surname>Edwards</surname><given-names>J.C.</given-names></name><name><surname>Petersen</surname><given-names>O.W.</given-names></name></person-group><article-title>Differential expression of a chloride intracellular channel gene, CLIC4, in transforming growth factor-beta1-mediated conversion of fibroblasts to myofibroblasts</article-title><source>American Journal of Pathology</source><volume>161</volume><year>2002</year><fpage>471</fpage><lpage>480</lpage><pub-id pub-id-type="pmid">12163372</pub-id></element-citation></ref><ref id="bib31"><label>31</label><element-citation publication-type="journal" id="sref31"><person-group person-group-type="author"><name><surname>Ulmasov</surname><given-names>B.</given-names></name><name><surname>Bruno</surname><given-names>J.</given-names></name><name><surname>Gordon</surname><given-names>N.</given-names></name><name><surname>Hartnett</surname><given-names>M.E.</given-names></name><name><surname>Edwards</surname><given-names>J.C.</given-names></name></person-group><article-title>Chloride intracellular channel protein-4 functions in angiogenesis by supporting acidification of vacuoles along the intracellular tubulogenic pathway</article-title><source>American Journal of Pathology</source><volume>174</volume><year>2009</year><fpage>1084</fpage><lpage>1096</lpage><pub-id pub-id-type="pmid">19197003</pub-id></element-citation></ref><ref id="bib32"><label>32</label><element-citation publication-type="journal" id="sref32"><person-group person-group-type="author"><name><surname>Fernandez-Salas</surname><given-names>E.</given-names></name><name><surname>Suh</surname><given-names>K.S.</given-names></name><name><surname>Speransky</surname><given-names>V.V.</given-names></name><name><surname>Bowers</surname><given-names>W.L.</given-names></name><name><surname>Levy</surname><given-names>J.M.</given-names></name><name><surname>Adams</surname><given-names>T.</given-names></name></person-group><article-title>mtCLIC/CLIC4, an organellular chloride channel protein, is increased by DNA damage and participates in the apoptotic response to p53</article-title><source>Molecular and Cellular Biology</source><volume>22</volume><year>2002</year><fpage>3610</fpage><lpage>3620</lpage><pub-id pub-id-type="pmid">11997498</pub-id></element-citation></ref><ref id="bib33"><label>33</label><element-citation publication-type="journal" id="sref33"><person-group person-group-type="author"><name><surname>Fernandez-Salas</surname><given-names>E.</given-names></name><name><surname>Sagar</surname><given-names>M.</given-names></name><name><surname>Cheng</surname><given-names>C.</given-names></name><name><surname>Yuspa</surname><given-names>S.H.</given-names></name><name><surname>Weinberg</surname><given-names>W.C.</given-names></name></person-group><article-title>p53 and tumor necrosis factor &#x003b1; regulate the expression of a mitochondrial chloride channel protein</article-title><source>Journal of Biological Chemistry</source><volume>274</volume><year>1999</year><fpage>36488</fpage><lpage>36497</lpage><pub-id pub-id-type="pmid">10593946</pub-id></element-citation></ref><ref id="bib34"><label>34</label><element-citation publication-type="journal" id="sref34"><person-group person-group-type="author"><name><surname>Shiio</surname><given-names>Y.</given-names></name><name><surname>Suh</surname><given-names>K.S.</given-names></name><name><surname>Lee</surname><given-names>H.</given-names></name><name><surname>Yuspa</surname><given-names>S.H.</given-names></name><name><surname>Eisenman</surname><given-names>R.N.</given-names></name><name><surname>Aebersold</surname><given-names>R.</given-names></name></person-group><article-title>Quantitative proteomic analysis of myc-induced apoptosis: a direct role for Myc induction of the mitochondrial chloride ion channel, mtCLIC/CLIC4</article-title><source>Journal of Biological Chemistry</source><volume>281</volume><year>2006</year><fpage>2750</fpage><lpage>2756</lpage><pub-id pub-id-type="pmid">16316993</pub-id></element-citation></ref><ref id="bib35"><label>35</label><element-citation publication-type="journal" id="sref35"><person-group person-group-type="author"><name><surname>Suh</surname><given-names>K.S.</given-names></name><name><surname>Mutoh</surname><given-names>M.</given-names></name><name><surname>Nagashima</surname><given-names>K.</given-names></name><name><surname>Fernandez-Salas</surname><given-names>E.</given-names></name><name><surname>Edwards</surname><given-names>L.E.</given-names></name><name><surname>Hayes</surname><given-names>D.D.</given-names></name></person-group><article-title>The organellular chloride channel protein CLIC4/mtCLIC translocates to the nucleus in response to cellular stress and accelerates apoptosis</article-title><source>Journal of Biological Chemistry</source><volume>279</volume><year>2004</year><fpage>4632</fpage><lpage>4641</lpage><pub-id pub-id-type="pmid">14610078</pub-id></element-citation></ref><ref id="bib36"><label>36</label><element-citation publication-type="journal" id="sref36"><person-group person-group-type="author"><name><surname>Efrat</surname><given-names>S.</given-names></name><name><surname>Fusco-DeMane</surname><given-names>D.</given-names></name><name><surname>Lemberg</surname><given-names>H.</given-names></name><name><surname>al Emran</surname><given-names>O.</given-names></name><name><surname>Wang</surname><given-names>X.</given-names></name></person-group><article-title>Conditional transformation of a pancreatic beta-cell line derived from transgenic mice expressing a tetracycline-regulated oncogene</article-title><source>Proceedings of the National Academy of Sciences</source><volume>92</volume><issue>8</issue><year>1995</year><fpage>3576</fpage><lpage>3580</lpage></element-citation></ref><ref id="bib37"><label>37</label><element-citation publication-type="journal" id="sref37"><person-group person-group-type="author"><name><surname>Lilla</surname><given-names>V.</given-names></name><name><surname>Webb</surname><given-names>G.</given-names></name><name><surname>Rickenbach</surname><given-names>K.</given-names></name><name><surname>Maturana</surname><given-names>A.</given-names></name><name><surname>Steiner</surname><given-names>D.F.</given-names></name><name><surname>Halban</surname><given-names>P.A.</given-names></name></person-group><article-title>Differential gene expression in well-regulated and dysregulated pancreatic beta-cell (MIN6) sublines</article-title><source>Endocrinology</source><volume>144</volume><issue>4</issue><year>2003</year><fpage>1368</fpage><lpage>1379</lpage><pub-id pub-id-type="pmid">12639920</pub-id></element-citation></ref><ref id="bib38"><label>38</label><element-citation publication-type="journal" id="sref38"><person-group person-group-type="author"><name><surname>Thorens</surname><given-names>B.</given-names></name><name><surname>Tarussio</surname><given-names>D.</given-names></name><name><surname>Maestro</surname><given-names>M.A.</given-names></name><name><surname>Rovira</surname><given-names>M.</given-names></name><name><surname>Heikkila</surname><given-names>E.</given-names></name><name><surname>Ferrer</surname><given-names>J.</given-names></name></person-group><article-title>Ins1Cre knock-in mice for beta cell-specific gene recombination</article-title><source>Diabetologia</source><year>2014 Dec 11</year><comment>[Epub ahead of print] PMID: 25500700</comment></element-citation></ref><ref id="bib39"><label>39</label><element-citation publication-type="journal" id="sref39"><person-group person-group-type="author"><name><surname>Cornu</surname><given-names>M.</given-names></name><name><surname>Modi</surname><given-names>H.</given-names></name><name><surname>Kawamori</surname><given-names>D.</given-names></name><name><surname>Kulkarni</surname><given-names>R.N.</given-names></name><name><surname>Joffraud</surname><given-names>M.</given-names></name><name><surname>Thorens</surname><given-names>B.</given-names></name></person-group><article-title>Glucagon-like peptide-1 increases beta-cell glucose competence and proliferation by translational induction of insulin-like growth factor-1 receptor expression</article-title><source>Journal of Biological Chemistry</source><volume>285</volume><issue>14</issue><year>2010</year><fpage>10538</fpage><lpage>10545</lpage><pub-id pub-id-type="pmid">20145256</pub-id></element-citation></ref><ref id="bib40"><label>40</label><element-citation publication-type="journal" id="sref40"><person-group person-group-type="author"><name><surname>Shevchenko</surname><given-names>A.</given-names></name><name><surname>Wilm</surname><given-names>M.</given-names></name><name><surname>Vorm</surname><given-names>O.</given-names></name><name><surname>Mann</surname><given-names>M.</given-names></name></person-group><article-title>Mass spectrometric sequencing of proteins silver-stained polyacrylamide gels</article-title><source>Analytical Chemistry</source><volume>68</volume><issue>5</issue><year>1996</year><fpage>850</fpage><lpage>858</lpage><pub-id pub-id-type="pmid">8779443</pub-id></element-citation></ref><ref id="bib41"><label>41</label><element-citation publication-type="journal" id="sref41"><person-group person-group-type="author"><name><surname>Wilm</surname><given-names>M.</given-names></name><name><surname>Shevchenko</surname><given-names>A.</given-names></name><name><surname>Houthaeve</surname><given-names>T.</given-names></name><name><surname>Breit</surname><given-names>S.</given-names></name><name><surname>Schweigerer</surname><given-names>L.</given-names></name><name><surname>Fotsis</surname><given-names>T.</given-names></name></person-group><article-title>Femtomole sequencing of proteins from polyacrylamide gels by nano-electrospray mass spectrometry</article-title><source>Nature</source><volume>379</volume><issue>6564</issue><year>1996</year><fpage>466</fpage><lpage>469</lpage><pub-id pub-id-type="pmid">8559255</pub-id></element-citation></ref><ref id="bib42"><label>42</label><element-citation publication-type="journal" id="sref42"><person-group person-group-type="author"><name><surname>Keller</surname><given-names>A.</given-names></name><name><surname>Nesvizhskii</surname><given-names>A.I.</given-names></name><name><surname>Kolker</surname><given-names>E.</given-names></name><name><surname>Aebersold</surname><given-names>R.</given-names></name></person-group><article-title>Empirical statistical model to estimate the accuracy of peptide identifications made by MS/MS and database search</article-title><source>Analytical Chemistry</source><volume>74</volume><issue>20</issue><year>2002</year><fpage>5383</fpage><lpage>5392</lpage><pub-id pub-id-type="pmid">12403597</pub-id></element-citation></ref><ref id="bib43"><label>43</label><element-citation publication-type="journal" id="sref43"><person-group person-group-type="author"><name><surname>Nesvizhskii</surname><given-names>A.I.</given-names></name><name><surname>Keller</surname><given-names>A.</given-names></name><name><surname>Kolker</surname><given-names>E.</given-names></name><name><surname>Aebersold</surname><given-names>R.</given-names></name></person-group><article-title>A&#x000a0;statistical model for identifying proteins by tandem mass spectrometry</article-title><source>Analytical Chemistry</source><volume>75</volume><issue>17</issue><year>2003</year><fpage>4646</fpage><lpage>4658</lpage><pub-id pub-id-type="pmid">14632076</pub-id></element-citation></ref><ref id="bib44"><label>44</label><element-citation publication-type="journal" id="sref44"><person-group person-group-type="author"><name><surname>Santin</surname><given-names>I.</given-names></name><name><surname>Moore</surname><given-names>F.</given-names></name><name><surname>Colli</surname><given-names>M.L.</given-names></name><name><surname>Gurzov</surname><given-names>E.N.</given-names></name><name><surname>Marselli</surname><given-names>L.</given-names></name><name><surname>Marchetti</surname><given-names>P.</given-names></name></person-group><article-title>PTPN2, a candidate gene for type 1 diabetes, modulates pancreatic b-cell apoptosis via regulation of the BH3-only protein Bim</article-title><source>Diabetes</source><volume>60</volume><year>2011</year><fpage>3279</fpage><lpage>3288</lpage><pub-id pub-id-type="pmid">21984578</pub-id></element-citation></ref><ref id="bib45"><label>45</label><element-citation publication-type="journal" id="sref45"><person-group person-group-type="author"><name><surname>Nogueira</surname><given-names>T.C.</given-names></name><name><surname>Paula</surname><given-names>F.M.</given-names></name><name><surname>Villate</surname><given-names>O.</given-names></name><name><surname>Colli</surname><given-names>M.L.</given-names></name><name><surname>Moura</surname><given-names>R.F.</given-names></name><name><surname>Cunha</surname><given-names>D.A.</given-names></name></person-group><article-title>GLIS3, a susceptibility gene for type 1 and type 2 diabetes, modulates pancreatic beta cell apoptosis via regulation of a splice variant of the BH3-only protein Bim</article-title><source>PLoS Genetics</source><volume>9</volume><issue>5</issue><year>2013</year><fpage>e1003532</fpage><pub-id pub-id-type="pmid">23737756</pub-id></element-citation></ref><ref id="bib46"><label>46</label><element-citation publication-type="journal" id="sref46"><person-group person-group-type="author"><name><surname>Kharroubi</surname><given-names>I.</given-names></name><name><surname>Ladri&#x000e8;re</surname><given-names>L.</given-names></name><name><surname>Cardozo</surname><given-names>A.K.</given-names></name><name><surname>Dogusan</surname><given-names>Z.</given-names></name><name><surname>Cnop</surname><given-names>M.</given-names></name><name><surname>Eizirik</surname><given-names>D.L.</given-names></name></person-group><article-title>Free fatty acids and cytokines induce pancreatic beta-cell apoptosis by different mechanisms: role of nuclear factor-kappaB and endoplasmic reticulum stress</article-title><source>Endocrinology</source><volume>145</volume><year>2004</year><fpage>5087</fpage><lpage>5096</lpage><pub-id pub-id-type="pmid">15297438</pub-id></element-citation></ref><ref id="bib47"><label>47</label><element-citation publication-type="journal" id="sref47"><person-group person-group-type="author"><name><surname>Karaskov</surname><given-names>E.</given-names></name><name><surname>Scott</surname><given-names>C.</given-names></name><name><surname>Zhang</surname><given-names>L.</given-names></name><name><surname>Teodoro</surname><given-names>T.</given-names></name><name><surname>Ravazzola</surname><given-names>M.</given-names></name><name><surname>Volchuk</surname><given-names>A.</given-names></name></person-group><article-title>Chronic palmitate but not oleate exposure induces endoplasmic reticulum stress, which may contribute to INS-1 pancreatic beta-cell apoptosis</article-title><source>Endocrinology</source><volume>147</volume><year>2006</year><fpage>3398</fpage><lpage>3407</lpage><pub-id pub-id-type="pmid">16601139</pub-id></element-citation></ref><ref id="bib48"><label>48</label><element-citation publication-type="journal" id="sref48"><person-group person-group-type="author"><name><surname>Eizirik</surname><given-names>D.L.</given-names></name><name><surname>Sammeth</surname><given-names>M.</given-names></name><name><surname>Bouckenooghe</surname><given-names>T.</given-names></name><name><surname>Bottu</surname><given-names>G.</given-names></name><name><surname>Sisino</surname><given-names>G.</given-names></name><name><surname>Igoillo-Esteve</surname><given-names>M.</given-names></name></person-group><article-title>The human pancreatic islet transcriptome: expression of candidate genes for type 1 diabetes and the impact of pro-inflammatory cytokines</article-title><source>PLoS Genetics</source><volume>8</volume><issue>3</issue><year>2012</year><fpage>e1002552</fpage><pub-id pub-id-type="pmid">22412385</pub-id></element-citation></ref><ref id="bib49"><label>49</label><element-citation publication-type="journal" id="sref49"><person-group person-group-type="author"><name><surname>Cnop</surname><given-names>M.</given-names></name><name><surname>Abdulkarim</surname><given-names>B.</given-names></name><name><surname>Bottu</surname><given-names>G.</given-names></name><name><surname>Cunha</surname><given-names>D.A.</given-names></name><name><surname>Igoillo-Esteve</surname><given-names>M.</given-names></name><name><surname>Masini</surname><given-names>M.</given-names></name></person-group><article-title>RNA sequencing identifies dysregulation of the human pancreatic islet transcriptome by the saturated fatty acid palmitate</article-title><source>Diabetes</source><volume>63</volume><year>2014</year><fpage>1978</fpage><lpage>1993</lpage><pub-id pub-id-type="pmid">24379348</pub-id></element-citation></ref><ref id="bib50"><label>50</label><element-citation publication-type="journal" id="sref50"><person-group person-group-type="author"><name><surname>Ortis</surname><given-names>F.</given-names></name><name><surname>Naamane</surname><given-names>N.</given-names></name><name><surname>Flamez</surname><given-names>D.</given-names></name><name><surname>Ladri&#x000e8;re</surname><given-names>L.</given-names></name><name><surname>Moore</surname><given-names>F.</given-names></name><name><surname>Cunha</surname><given-names>D.A.</given-names></name></person-group><article-title>Cytokines interleukin-1beta and tumor necrosis factor-alpha regulate different transcriptional and alternative splicing networks in primary beta-cells</article-title><source>Diabetes</source><volume>59</volume><year>2010</year><fpage>358</fpage><lpage>374</lpage><pub-id pub-id-type="pmid">19934004</pub-id></element-citation></ref><ref id="bib51"><label>51</label><element-citation publication-type="journal" id="sref51"><person-group person-group-type="author"><name><surname>Dupraz</surname><given-names>P.</given-names></name><name><surname>Rinsch</surname><given-names>C.</given-names></name><name><surname>Pralong</surname><given-names>W.F.</given-names></name><name><surname>Rolland</surname><given-names>E.</given-names></name><name><surname>Zufferey</surname><given-names>R.</given-names></name><name><surname>Trono</surname><given-names>D.</given-names></name></person-group><article-title>Lentivirus-mediated Bcl-2 expression in betaTC-tet cells improves resistance to hypoxia and cytokine-induced apoptosis while preserving in&#x000a0;vitro and in&#x000a0;vivo control of insulin secretion</article-title><source>Gene Therapy</source><volume>6</volume><year>1999</year><fpage>1160</fpage><lpage>1169</lpage><pub-id pub-id-type="pmid">10455420</pub-id></element-citation></ref><ref id="bib52"><label>52</label><element-citation publication-type="journal" id="sref52"><person-group person-group-type="author"><name><surname>Allison</surname><given-names>J.</given-names></name><name><surname>Thomas</surname><given-names>H.</given-names></name><name><surname>Beck</surname><given-names>D.</given-names></name><name><surname>Brady</surname><given-names>J.L.</given-names></name><name><surname>Lew</surname><given-names>A.M.</given-names></name><name><surname>Elefanty</surname><given-names>A.</given-names></name></person-group><article-title>Transgenic overexpression of human Bcl-2 in islet beta cells inhibits apoptosis but does not prevent autoimmune destruction</article-title><source>International Immunology</source><volume>12</volume><year>2000</year><fpage>9</fpage><lpage>17</lpage><pub-id pub-id-type="pmid">10607745</pub-id></element-citation></ref><ref id="bib53"><label>53</label><element-citation publication-type="journal" id="sref53"><person-group person-group-type="author"><name><surname>Zhou</surname><given-names>Y.P.</given-names></name><name><surname>Pena</surname><given-names>J.C.</given-names></name><name><surname>Roe</surname><given-names>M.W.</given-names></name><name><surname>Mittal</surname><given-names>A.</given-names></name><name><surname>Levisetti</surname><given-names>M.</given-names></name><name><surname>Baldwin</surname><given-names>A.C.</given-names></name></person-group><article-title>Overexpression of Bcl-x(L) in beta-cells prevents cell death but impairs mitochondrial signal for insulin secretion</article-title><source>American Journal of Physiology. Endocrinology and Metabolism</source><volume>278</volume><issue>2</issue><year>2000</year><fpage>E340</fpage><lpage>E351</lpage><pub-id pub-id-type="pmid">10662719</pub-id></element-citation></ref></ref-list><sec id="appsec1"><title>Conflict of interest</title><p>None declared.</p></sec><ack id="ack0010"><title>Acknowledgments</title><p>We acknowledge Dr. Manfredo Quadroni and Dr. Patrice Waridel from the protein analysis facility of the Center for Integrative Genomics of the UNIL, for the mass spectrometry analysis.</p></ack><fn-group><fn id="d32e571"><label>a</label><p>Grant support: This study was supported by grants from the <funding-source id="gs1">Swiss National Science Foundation</funding-source> (3100A0B-128657 to BT), a <funding-source id="gs2">European Research Council</funding-source> (268946) advanced grant (INSIGHT, to BT), an <funding-source id="gs4">Innovative Medicine Initiative Joint Undertaking</funding-source> grant No. 155005 (IMIDIA), resources of which are composed of financial contributions from the European Union's <funding-source id="gs3">Seventh Framework Programme</funding-source> (FP7/2007-2013) and EFPIA companies in kind contribution and the European Union Framework Program 7 Collaborative Project BetaBat to BT and DE.</p></fn></fn-group></back><floats-group><fig id="fig1"><label>Figure&#x000a0;1</label><caption><p>Clic4 is a cytokine-induced protein and its silencing protects against cytokine-induced apoptosis. &#x003b2;TC-tet cells (A,B) or primary mouse islets (C,D) were left untreated or treated with cytokines (IL-1&#x003b2;, IFN-&#x003b3;, TNF-&#x003b1;) for 15&#x000a0;h and Clic4 expression was measured by western blot analysis (A,C) and quantitated by densitometry analysis (B,D). Data are mean&#x000a0;&#x000b1;&#x000a0;SD, <italic>n</italic>&#x000a0;=&#x000a0;3 independent experiments. (E&#x02013;H) &#x003b2;TC-tet cells were transfected with <italic>siCT</italic> or <italic>siClic4</italic>. 48&#x000a0;h later they were exposed to 100&#x000a0;nM exendin-4 (Ex4) or left untreated for 9&#x000a0;h and then treated with cytokines for 15&#x000a0;h. The efficacy of Clic4 silencing was tested by western blot analysis (E). Apoptosis was measured by TUNEL assay (F) or by western blot analysis of cleaved caspase-3; (G) western blot, (H) quantitation by densitometry analysis. The data are means&#x000a0;&#x000b1;&#x000a0;SD from three independent experiments. *<italic>p</italic>&#x000a0;&#x0003c;&#x000a0;0.05; **<italic>p</italic>&#x000a0;&#x0003c;&#x000a0;0.01; ***<italic>p</italic>&#x000a0;&#x0003c;&#x000a0;0.001. &#x003b2;TC-tet cells (I) or Min6(B1) cells (J) were transfected with <italic>siCT</italic> or <italic>siClic4</italic>. 72&#x000a0;h&#x000a0;later, they were exposed to either 2 or 20&#x000a0;mM glucose for 1&#x000a0;h in the presence or absence of 100&#x000a0;nM exendin-4 (Ex-4). Insulin secretion is expressed as percent of total intracellular content. The data are the means&#x000a0;&#x000b1;&#x000a0;SD from three independent experiments.</p></caption><graphic xlink:href="gr1"/></fig><fig id="fig2"><label>Figure&#x000a0;2</label><caption><p><italic>Clic4</italic> silencing increases Bcl-2 and Bad expression as well as Bad phosphorylation. (A) Western blot analysis of the indicated proteins and of the phosphorylated form of Bad in &#x003b2;TC-tet cells transfected with <italic>siCT</italic> or <italic>siClic4</italic> and treated 48&#x000a0;h later with or without cytokines for an additional 15&#x000a0;h period. Densitometry analysis of the proteins normalized to &#x003b2;-actin is shown in (B&#x02013;G) as is the ratio of phosphorylated Bad (pBad) to total Bad (D). The data are the means&#x000a0;&#x000b1;&#x000a0;SD from three independent experiments. *<italic>p</italic>&#x000a0;&#x0003c;&#x000a0;0.05; **<italic>p</italic>&#x000a0;&#x0003c;&#x000a0;0.01.</p></caption><graphic xlink:href="gr2"/></fig><fig id="fig3"><label>Figure&#x000a0;3</label><caption><p><italic>Clic4</italic> silencing did not affect expression of PUMA, Bim<sub>s</sub>, Bim<sub>L</sub>, Bim<sub>EL</sub> or the phosphorylation of Bim and JNK. (A) &#x003b2;TC-tet cells were transfected with <italic>siCT</italic> or <italic>siClic4</italic>. After 48&#x000a0;h, cells were left untreated or treated with cytokines for 15&#x000a0;h and expression of the indicated proteins was evaluated by western blot analysis. Densitometry analysis of protein expression normalized to &#x003b2;-actin is shown in (B&#x02013;G). The data are means&#x000a0;&#x000b1;&#x000a0;SD from three independent experiments. *<italic>p</italic>&#x000a0;&#x0003c;&#x000a0;0.05; **<italic>p</italic>&#x000a0;&#x0003c;&#x000a0;0.01.</p></caption><graphic xlink:href="gr3"/></fig><fig id="fig4"><label>Figure&#x000a0;4</label><caption><p><italic>Clic4</italic> silencing increases the half-lives of Bcl-2 and Bad. (A) &#x003b2;TC-tet cells were transfected with <italic>siCT</italic> or <italic>siClic4</italic>. 48&#x000a0;h later they were left untreated or were treated with cycloheximide for the indicated periods of time, and Bcl-2 and Bad expression was quantitated by western blot analysis. (B, C) Densitometry analysis of the Bcl2 (B) and Bad (C) expression data were plotted on a logarithmic scale. The protein half-lives (t<sub>1/2</sub>) were calculated by regression analysis (inset). The data are means&#x000a0;&#x000b1;&#x000a0;SD from three independent experiments.</p></caption><graphic xlink:href="gr4"/></fig><fig id="fig5"><label>Figure&#x000a0;5</label><caption><p>Generation of <italic>&#x003b2;Clic4KO</italic> mice and resistance to apoptosis of <italic>&#x003b2;Clic4KO</italic> &#x003b2;-cells. (A) Top: structure of the wild type <italic>Clic4</italic> allele and of the targeting vector; middle: structure of the <italic>Clic4</italic><sup><italic>flox</italic></sup> allele; bottom: structure of the <italic>Clic4</italic><sup>&#x00394;</sup> allele after <italic>Ins</italic><sup><italic>Cre</italic></sup>-mediated recombination. (B) PCR analysis of <italic>Clic4</italic> recombination using the P1 and P2 primers (see A). (C) Quantitative RT-PCR analysis of <italic>Clic4</italic> expression in islets from <italic>&#x003b2;Clic4KO</italic> or control mice. (D, E) Islets from Control or <italic>&#x003b2;Clic4KO</italic> mice were plated on extracellular matrix-coated dishes for 6 days to form monolayers. (D) Cells were then left untreated or pre-incubated with 100&#x000a0;nM exendin-4 (Ex4) for 9&#x000a0;h and then treated with cytokines for 15&#x000a0;h. (E) Cells were left untreated or treated with 1&#x000a0;mM palmitic acid (PA) with or without 100&#x000a0;nM exendin-4 (Ex-4) for 48&#x000a0;h. In (D) and (E), apoptosis was measured by TUNEL assay and is expressed as percentage of TUNEL-positive cells over total DAPI positive cells. The data are the means&#x000a0;&#x000b1;&#x000a0;SD from three independent experiments. *<italic>p</italic>&#x000a0;&#x0003c;&#x000a0;0.05; **<italic>p</italic>&#x000a0;&#x0003c;&#x000a0;0.01; ***<italic>p</italic>&#x000a0;&#x0003c;&#x000a0;0.001.</p></caption><graphic xlink:href="gr5"/></fig><fig id="fig6"><label>Figure&#x000a0;6</label><caption><p>Increased expression of Bcl-2, Bcl-xL, Bad and pBad in islets from <italic>&#x003b2;Clic4KO</italic> mice. (A&#x02013;D) Islets from <italic>&#x003b2;Clic4KO</italic> or control mice were left untreated or treated with cytokines for 15&#x000a0;h and expression levels of <italic>Clic4</italic>, <italic>Bcl-2</italic>, <italic>Bcl-xL</italic> and <italic>Bad</italic> mRNAs were assessed by qRT-PCR; expression levels were normalized to <italic>tbp</italic> mRNA levels and expressed relative to the levels found in non-treated control islets. (E) Western blot analysis of the indicated proteins in the islets of control and <italic>&#x003b2;Clic4KO</italic> mice treated or not with cytokines. (F&#x02013;J) Densitometry analysis of the proteins normalized to &#x003b2;-actin and of the ratio of pBad/Bad. The data are means&#x000a0;&#x000b1;&#x000a0;SD from three independent experiments. *<italic>p</italic>&#x000a0;&#x0003c;&#x000a0;0.05; **<italic>p</italic>&#x000a0;&#x0003c;&#x000a0;0.01; ***<italic>p</italic>&#x000a0;&#x0003c;&#x000a0;0.001.</p></caption><graphic xlink:href="gr6"/></fig><fig id="fig7"><label>Figure&#x000a0;7</label><caption><p>Mass-spectrometry analysis of proteins associated with Clic4. (A) Clic4 was immunoprecipitated from 1&#x000a0;mg of &#x003b2;TC-tet cell lysate proteins using the C- or N-terminal Clic4 antibodies; rabbit IgGs were used as a negative immunoprecipitation control. The immunoprecipitated proteins were analyzed by western blotting for co-immunoprecipitation with Bcl2 and Bad, which was negative. (B) The immunoprecipipates of (A) were also subjected to SDS-PAGE followed by Coomassie blue staining. Each gel lanes was cut into six regions, digested with trypsin and analyzed by mass spectrometry analysis for analysis of proteins specifically associated with Clic4 (see <xref rid="tbl1" ref-type="table">Table&#x000a0;1</xref>).</p></caption><graphic xlink:href="gr7"/></fig><table-wrap id="tbl1" position="float"><label>Table&#x000a0;1</label><caption><p>List of Clic4-binding proteins identified by mass-spectrometry. Proteins co-immunoprecipitated with Clic4 from &#x003b2;TC-tet cells (<xref rid="fig7" ref-type="fig">Figure&#x000a0;7</xref>) were identified by mass spectrometry. Most of the proteins were pulled-down with the C-terminal antibody. *Indicates the proteins pulled-down with the N-terminal antibody and ** indicates those pulled-down with both C- and N-terminal antibodies.</p></caption><table frame="hsides" rules="groups"><thead><tr><th colspan="4">List of Clic4-binding proteins</th></tr></thead><tbody><tr><td colspan="2"><bold>Proteins involved in protein biosynthesis</bold></td><td colspan="2"><bold>Proteins involved in cell cycle</bold></td></tr><tr><td>1</td><td>Ile-tRNA synthetase</td><td>46</td><td>DNA replication licensing factor MCM2</td></tr><tr><td>2</td><td>Arg-tRNA synthetase</td><td>47</td><td>Replication factor C subunit 5</td></tr><tr><td>3</td><td>Met-tRNA synthetase</td><td>48</td><td>Chromosome transmission fidelity protein 18 homolog</td></tr><tr><td>4</td><td>Leu-tRNA synthetase</td><td>49</td><td>Paired amphipathic helix protein Sin3a</td></tr><tr><td>5</td><td>Asp-tRNA synthetase</td><td>50</td><td>CD2-associated protein</td></tr><tr><td>6</td><td>Lys-tRNA synthetase</td><td>51</td><td>Sister chromatid cohesion protein DCC1</td></tr><tr><td>7</td><td>Ala-tRNA synthetase</td><td>52*</td><td>Proliferating cell nuclear antigen</td></tr><tr><td>8</td><td>Thr-tRNA synthetase</td><td>53</td><td>Centrosomal protein of 89&#x000a0;kDa</td></tr><tr><td>9</td><td>Glu-Pro-tRNA synthetase</td><td>54</td><td>Kinetochore-associated protein NSL1 homolog</td></tr><tr><td>10</td><td>AIMP1/p43</td><td>55</td><td>Kinetochore-associated protein DSN1 homolog</td></tr><tr><td>11</td><td>AIMP2/p38</td><td>56</td><td>Polyamine-modulated factor 1</td></tr><tr><td>12</td><td>AIMP3/p18</td><td>57</td><td>Protein CASC5</td></tr><tr><td>13&#x02013;17</td><td>eIF3 subunit B, A, H, M, E</td><td>58*</td><td>NIF3-like protein 1</td></tr><tr><td>18**</td><td>40S ribosomal protein S9</td><td>59*</td><td>Cyclin-G-associated kinase</td></tr><tr><td>19**</td><td>60S ribosomal protein L17</td><td colspan="2"><bold>Kinases/Phosphatases</bold></td></tr><tr><td colspan="2"><bold>Proteins involved in apoptosis</bold></td><td>60-61</td><td>cAMP-dependent protein kinase type I-alpha and type II-alpha.</td></tr><tr><td>10</td><td>AIMP1/p43</td><td>62*</td><td>Serine/threonine-protein kinase MRCK beta</td></tr><tr><td>11</td><td>AIMP2/p38</td><td>63*</td><td>Protein phosphatase 1 regulatory subunit 12A</td></tr><tr><td>12</td><td>AIMP3/p18</td><td>64*</td><td>Myotubularin-related protein 5</td></tr><tr><td colspan="2"><bold>Proteins involved in protein degradation</bold></td><td>65*</td><td>Serine/threonine-protein phosphatase PP1-beta catalytic subunit</td></tr><tr><td>20&#x02013;26</td><td>26S proteasome non-ATPase regulatory subunit 2, 1, 11, 13, 6, 7, 5.</td><td>66</td><td>Type II inositol 1,4,5-trisphosphate 5-phosphatase</td></tr><tr><td>27&#x02013;31</td><td>26S protease regulatory subunit 8, 6B, 7, 10B, 4.</td><td colspan="2"><bold>Proteins involved in GTPase activity</bold></td></tr><tr><td>32</td><td>F-box only protein 28</td><td>67</td><td>Arf-GAP</td></tr><tr><td>33</td><td>DNA damage-binding protein 1</td><td>68</td><td>RhoGEF (Factor 12 and 1)</td></tr><tr><td colspan="2"><bold>Proteins transport</bold></td><td>69</td><td>Dedicator of cytokinesis protein 7</td></tr><tr><td>34</td><td>Kinesin-1 heavy chain</td><td>70</td><td>SH3 domain-binding protein 1</td></tr><tr><td>35&#x02013;37</td><td>Kinesin light chain 1, 2 and 4</td><td>71*</td><td>Neurofibromin</td></tr><tr><td>38</td><td>Kinesin-like protein KIF11</td><td>72*</td><td>BTB/POZ domain-containing protein KCTD12</td></tr><tr><td>39</td><td>14-3-3 protein epsilon</td><td>73*</td><td>GTPase-activating protein and VPS9 domain-containing protein 1</td></tr><tr><td>40</td><td>Torsin-1A-interacting protein 1</td><td>74*</td><td>Jouberin</td></tr><tr><td>41</td><td>AP-3 complex subunit beta-1</td><td colspan="2"><bold>Others</bold></td></tr><tr><td>42*</td><td>Membrane-associated phosphatidylinositol transfer protein 1</td><td>43*</td><td>SUN domain-containing protein 2</td></tr><tr><td>75</td><td>Spectrin beta chain</td><td>76</td><td>Spectrin alpha chain</td></tr><tr><td>44</td><td>Myomegalin</td><td>77</td><td>F-actin-capping protein subunit beta</td></tr><tr><td colspan="2"><bold>Proteins involved in cell cycle</bold></td><td>78*</td><td>3-hydroxyisobutyrate dehydrogenase, mitochondrial</td></tr><tr><td>45</td><td>DNA replication licensing factor MCM3</td><td/><td/></tr></tbody></table><table-wrap-foot><fn><p>Unmarked, protein pull-down with C-ter Ab; *, protein pull-down with N-ter Ab; **, protein pull down by both C- and N-ter Ab.</p></fn></table-wrap-foot></table-wrap></floats-group></article>